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Summary 
 
Treating people living with severe health conditions has, and always will be, a 
fundamental part of the National Health Service. Given the complex nature of 
conditions such as Huntington’s Disease and Cancer, research exploring the impact 
severe health conditions can have on those affected is of paramount importance. 
  
Chapter one is a systematic review utilising a meta-ethnographic approach to explore 
qualitative research portraying people’s experiences of genetic testing for 
Huntington’s Disease (HD). Electronic databases cataloguing relevant research were 
searched which, combined with manual searches, resulted in eleven studies suitable 
for inclusion. Three meta-themes were identified, highlighting the complex and 
individual nature of undergoing genetic testing, together with the potential emotional 
and behavioural consequences. The implications of such findings, together with 
clinical recommendations are considered.  
 
There is a dearth of research exploring what it is like to live with cancer as a young 
person in the United Kingdom. Chapter two is a qualitative research study that 
explored the lived experiences of young people (13-24 years) who had recently been 
diagnosed with cancer. Utilising an interpretative phenomenological approach, 
emergent findings related to the adversarial nature of being diagnosed with cancer, 
with young people speaking to the unjust nature of battling this disease at such a 
youthful age, questioning their identity and having to navigate a new, and at times, 
uncertain world. The clinical and service implications of these findings are 
discussed, alongside areas of future research.  
 
Chapter three represents the author’s reflective account of conducting this research. 
From exploring initial motivations, to evaluating the role of “insider” and “outsider” 
perspectives, the author explores the reciprocal nature of conducting qualitative 
research, particularly in relation to the mutuality felt between himself and his 
participants.  
Overall word count: 19,116
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People’s experiences of predictive genetic testing for Huntington’s 
disease: A systematic review of the qualitative research 
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for this chapter, excluding abstract, figures, tables and references, is 7,964 
 
 
 
 
 
 
2 
 
1.0 Abstract  
 
Purpose: Huntington’s disease (HD) is a neurodegenerative genetic condition with 
no current cure.  While the psychological impact of testing has been explored in 
previous research, quantitative studies have yielded mixed results. The aim of this 
systematic review was to produce a synthesis of the qualitative evidence base 
examining individuals’ experiences of predictive genetic testing for HD.   
Study Design: A meta-ethnographic synthesis was conducted. A total of five 
electronic databases cataloguing relevant research (e.g. psychology, nursing and 
medicine) were searched, resulting in a total of 11 studies for analysis.   
Major findings: Three meta-themes were identified: ‘discovering the truth, ‘facing 
the truth’ and ‘sharing the truth’. People’s experiences of testing varied, with some 
associating the experience with affirmative life decisions, whilst others spoke about 
the distress and difficulty that followed the result. Various factors that contributed to 
these experiences were explored.  
Main conclusions: Whilst there were commonalities across the study’s findings, 
there were also divergences, highlighting the complex and individual nature of 
genetic testing for HD. With potential significant emotional and behavioural 
consequences, clinical and research implications are considered.  
Key Words: Huntington’s Disease, HD, Genetic Testing, Gene Positive, 
Experiences, Meta-ethnographic 
Abstract word count: 188 
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1.1 Introduction 
 
 
1.1.1 Genetic Testing  
Genetic testing is a process defined as “the analysis of human DNA1, RNA2, 
chromosomes, proteins, and certain metabolites in order to detect heritable disease-
related genotypes, mutations, phenotypes, or karyotypes for clinical purposes” 
(Burke, 2002, p. 1867). Scientific advances have seen substantial progress in the 
understanding of human genetics. Whilst knowledge of the human genome 
sequence has grown for many diseases, advances have arguably created more lines 
of enquiry. Furthermore, transforming findings into clinical intervention is not 
straightforward (Miller, 2004)  
 
It is proposed that in the future, information about our genes will lead to the 
routine use of diagnostic testing, based on genetic markers for common diseases 
such as asthma, coronary artery disease, and diabetes (Miller, 2010). There is also 
the potential for genetic information to influence treatment of human diseases. 
Such prospects include ‘gene therapy’ for diseases such as cancer, where the 
potential to replace ‘faulty’ or ‘missing genes’ may become a reality. With the 
number of available genetic tests expanding, research exploring how such tests are 
applied, is of great importance (Amos & Patnaik, 2002). 
 
Currently, there are three main categories of genetic testing which examine changes 
or mutations: diagnostic, carrier screening and predictive (Miller, 2010). 
                                                        
1 Deoxyribonucleic acid 
2 Ribonucleic acid 
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Diagnostic testing is used to validate a diagnosis in people already displaying 
clinical symptoms, whilst carrier screening tests a person free from disease (a 
carrier) who could potentially pass on this change to their offspring. Finally, 
predictive genetic tests can identify the presence of mutation that can cause a 
disease in people who are currently asymptomatic (Burke, 2002).   
 
There are a variety of benefits to predictive genetic testing. For example, tests are 
now available to identify genes that increase the likelihood of a variety of cancers. 
This has helped people become more aware of potential symptoms and spot early 
signs of the disease, aiding early detection and treatment (Miller, 2010). However, 
uptake of genetic testing outside of cancer related conditions is limited (Forrest, 
Delatycki, Skene & Aitken, 2011). Since predictive testing does not always lead to 
treatment, its use for potentially fatal diseases with limited or no treatment options, 
has been shown to lead to psychological distress and needs to be considered 
carefully (Oster et al., 2008).   
 
1.1.2 Huntington’s Disease  
Huntington’s disease (HD) is an autosomal dominant neurodegenerative condition 
characterised by involuntary movements, psychiatric manifestations and cognitive 
decline (Sturrock & Leavitt, 2010; NHS.uk, 2018). It has a reported worldwide 
prevalence rate of between 4 and 12 people per 100,000 and a disease trajectory of 
10-20 years before death (Myers, 2004; Pringsheim et al., 2012; NHS.uk, 2018). The 
average age of onset is between 40 and 45 years and there is currently no cure, with 
treatment focusing on symptom management and quality of life (Sturrock & Leavitt, 
2010).  
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Directed mutation analysis (DMA) developed in 1993, means people at risk of 
developing HD can discover their carrier status with 100% accuracy (Evers-
Kiebooms & Decruyenare, 1993). Given the definitive and potentially life changing 
implications of predictive genetic testing, research examining the psychological 
implications is crucial (Leventhal, Leventhal & Contrada, 1998; Leventhal, 
Leventhal & Cameron, 2001; Rolland & Williams, 2005) 
 
1.1.2.1 Genetic testing for Huntington’s Disease  
Uptake in predictive genetic testing, by asymptomatic family members at risk of 
developing HD, has been consistently low (Sobel & Cowan, 2000). Recently, Baig et 
al. (2016) conducted the largest UK study on predictive genetic testing for HD, 
examining 22 years of anonymised data. Findings revealed that the majority of 
people at risk of HD (>80%) had not undergone predictive testing. With future trials 
and therapies for HD likely targeting presymptomatic individuals, research looking 
at factors impacting on test uptake is of significant public health value (Baig et al., 
2016). 
 
1.1.2.2    Psychological Impact of predictive genetic testing for Huntington’s Disease  
Researchers and clinicians have attempted to apply several psychological models to 
understand people’s reactions to predictive genetic testing and HD. One of the most 
notable in relation to its application and evidence base, is the Common-Sense Model 
of self-regulation of health and illness developed by Leventhal et al. (1998).  
Employing this model to help explain potential reactions to a diagnosis of HD 
suggests that given its uncontrollable and fatal consequences, the possibility of such 
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a diagnosis would be appraised as highly threatening and extremely distressing.  
Despite this, evidence relating to psychological impact is equivocal, with studies 
employing various methodologies leading to different findings (Duncan et al., 2008). 
 
1.1.3 Quantitative research  
Decruyenaere et al. (1996) assessed the impact of predictive genetic testing for 53 
participants using pre- and post-test psychometric measurements and self-report data. 
Findings revealed no significant change in anxiety and depression in the case of a 
positive test result. Furthermore, researchers found the mean personality profile 
including ego strength, remained unchanged one year after the test. Timman, Kievit 
and Tibben (2004) measured psychological stress responses amongst 49 participants 
(20 carriers and 29 non-carriers). Results highlighted no significant differences 
amongst the two groups, with only slight changes from baseline observed three years 
post testing. Furthermore, hopelessness scales only highlighted a difference in 
carriers one week after disclosure, with scores returning to similar levels after six 
months.   
 
Crozier, Robertson, and Dale (2015) systematically reviewed 8 studies using 
standardised measures to examine pre-symptomatic psychological distress associated 
with DMA genetic testing. Results suggested no significant differences in 
psychological impact amongst non-carriers and those found to have the disease. 
Further analysis revealed that people who were symptomatic did show increased 
signs of psychological distress compared to non-symptomatic carriers and non-
carriers, suggesting that distress may be an early manifestation of the disease rather 
than an implication or awareness of gene status (Licklederer, Wolff & Barth, 2008).   
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1.1.3.1Methodological Limitations  
Quantitative literature, together with the review by Crozier et al. (2015) has focused 
on papers utilising standardised measures. Despite finding certain differences in 
psychological impact between carriers and non-carriers, the overall outcome of 
quantitative research to date implies no significant adverse impact irrespective of test 
outcome. However, there are several methodological and conceptual limitations to 
this type of research.  
 
Only one of the studies included in the review by Crozier et al. (2015) utilised a 
specific measure for HD (Unified Huntington’s Disease Rating Scale, Witjes-Ané et 
al., 2002), with all other studies using standardised generic measures of 
psychological constructs found in the general population. Crozier et al. (2015) 
suggested the use of such measures may not be sensitive enough to detect emotional 
reactions reported by individuals experiencing this particular phenomenon. 
Furthermore, the review recognised these measures were employed in a pragmatic 
manner to assess impact, and as such were not explicitly derived from a theoretical 
understanding of how genetic testing might affect people’s lives. Crozier et al. 
(2015) concluded that the lack of clinically significant findings when using 
psychometric instruments may represent absence of distress, however suggested 
further research was needed to ensure these findings were not an artefact generated 
by the use of unsuitable measures. Furthermore, given the low uptake in predictive 
genetic testing, such findings only reflect a minority of experiences, and as such 
more in depth qualitative enquiry examining people’s experiences would be helpful.  
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1.1.4 Qualitative Research  
Qualitative research examining people’s experiences of genetic testing for HD has 
revealed a more diverse range of experiences than indicated by quantitative research. 
A study by Hagberg, Winnberg, and Bui (2011) used content analysis to explore 
experiences of living as a mutation carrier of HD. Common themes of distress 
amongst carriers were found and included feelings of fear, regret and hopelessness 
(Hagberg et al., 2011). Schwartz (2010) used a holistic content approach to explore 
people’s experiences of undergoing genetic testing for HD. Data analysis revealed 
the presence of several distressing emotions, such as shock, fear and frustration 
(Schwartz, 2010). Adverse psychological consequences have also been reported, 
regardless of test outcome, with carriers often struggling to come to terms with a 
life-limiting disease, and non-carriers reporting feelings associated with survivor 
guilt, as well as emotional numbness and difficulties within the family (Hayden & 
Bombard, 2005).  
 
1.1.5 Rationale  
Despite most quantitative research examining the impact of predictive genetic testing 
for people at risk of HD reporting non-significant results, qualitative studies have 
shown common themes associated with distress and difficulty (Broadstock, Michie, 
& Marteau, 2000; Meiser & Dunn, 2000; Licklederer, Wolff, & Barth, 2008; 
Schwartz, 2010; Hagberg et al., 2011; Crozier et al., 2015). The increase in 
qualitative research in this field has now changed the focus of enquiry to include 
exploration of individual experiences of genetic testing and as such has the potential 
to provide a more in-depth picture. 
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1.1.6 Aims of current review  
Previous qualitative research examining the effects of predictive genetic testing has 
found varying psychological consequences. Given the deteriorating and incurable 
nature of HD, together with the introduction of mutation analysis, a more in-depth 
enquiry of qualitative research exploring the impact of predictive testing, must be 
considered (Dudok DeWit et al., 1998). With recent quantitative reviews by 
Broadstock et al. (2000), Meiser and Dunn (2000) and Crozier et al. (2015) reporting 
no significant clinical distress amongst those undergoing predictive genetic testing 
for HD, a systematic review of the qualitative evidence base is required, to establish 
a more detailed insight into people’s lived experiences.    
 
The aim of this current review is to provide an interpretative qualitative synthesis of 
the empirical evidence relating to the experiences and psychological implications of 
predictive genetic testing for HD, in at risk individuals. A secondary aim is to 
explore what information qualitative studies provide in relation to uptake of 
predictive genetic testing.  It is hoped the findings of the review will inform future 
research and support clinicians in informing pre-and post-counselling support.  
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1.2 Method 
 
1.2.1. Search strategy   
Ethical approval for this review was sought from Coventry University Ethics 
Committee (See Appendix B). A systematic investigation of literature examining 
‘Experiences of predictive genetic testing for Huntington’s disease’ was conducted 
in October 2017 and updated in March 2018. Preceding the systematic search, the 
researcher and subject librarian examined relevant database specific thesauruses and 
keyword heading lists (e.g. Medical Subject Headings; MeSH) in order to identify 
further appropriate terms. Table 1.1 provides a list of the databases cataloguing 
pertinent research (i.e. those associated with psychology, medicine and nursing).  
Reference sections of included articles were hand-searched for additional studies. 
Online attempts to acquire relevant grey literature were also undertaken i.e. Google 
Scholar, Open Grey and Open Door. Table 1.2 outlines specific search terms, 
together with the approaches to Boolean and Truncation operators employed in the 
search. Search terms were isolated to title, abstract and key words of studies to 
increase probability of identifying relevant research.   
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Table 1.1 Databases included in the systematic investigation  
 
 Table 1.2 Search terms, truncation and Boolean operators  
 
 
1.2.2 Eligibility Criteria  
Original qualitative research and mixed methods papers pertaining detailed 
qualitative accounts of peoples lived experiences of predictive genetic testing for HD 
were included. While there were no restrictions placed on the gender of participants, 
research that focused on people who were not at risk of developing HD or were at 
risk of developing other genetic conditions were excluded. No limits relating to 
qualitative method, sample size or recruitment strategies were implemented. 
Database  Host  
AMED (Allied and complementary Medicine 
Database) 
Ovid  
CINAHL (Cumulative Index to Nursing and 
Allied Health Language)  
EBSCO  
PsychINFO (Psychological Information 
Database)  
Ovid 
MEDLINE (Medical Literature Analysis and 
Retrieval System Online)  
Ovid  
Scopus  Elsevier 
Concept  Search terms  
Experience  Experience or Impact or Effect or Psychological 
Consequence or Consequence  
Genetic Testing  Genetic or Test* or predictive or Screening or 
Counselling  
Huntington’s Disease  Huntington’s Disease, Huntington’s or HD  
Qualitative Research  Qualitative Research/ or Experience or IPA or 
Grounded Theory or Thematic Analysis or 
Discourse Analysis or Content Analysis   
12 
 
However, quantitative research or non-original articles (i.e. reviews or books) were 
excluded. Due to medical advances in screening and the arrival of DMA in 1993, 
research before this date was excluded. Research with participants under the age of 
18 was excluded in line with the NHS age limit for genetic screening. Table 1.3 
provides a summary of the inclusion and exclusion criteria.  
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 Table 1.3. Inclusion and Exclusion Criteria 
 
 
1.2.3. Study Identification 
The process of study selection was recorded using the “Preferred Reporting Items for 
Systematic Reviews and Meta-analyses” (PRISMA) flow diagram shown in Figure 
1.1. A total of 534 original studies were identified from electronic database searches, 
with no additional “grey” articles being identified. Seventy-four duplications were 
detected and removed by computer programmes and the author following crosscheck 
examination. Titles and abstracts of the remaining 460 articles were inspected for 
inclusion. A total of 421 studies were eliminated in line with the review’s eligibility 
Criteria  Inclusion   Exclusion  
Experiences of predictive 
genetic testing  
Research exploring experiences 
of individuals undergoing 
predictive genetic testing  
Research exploring 
individuals at risk of HD 
who are not in the process 
of undertaking/have not 
undergone, predictive 
genetic testing 
Research Design  Qualitative Research  
Mixed Methods (Qualitative 
Aspect) 
Quantitative research, non-
original articles (e.g. 
reviews, books or 
editorials)  
Sample   Humans  Animals  
Genetic Status  At risk of developing HD  Not at risk of developing 
HD/other genetic 
conditions  
Age  >18 <18 
Year of publication  ≥ 1993 <1993 
Gender  Male and Female  N/A 
Language  English  Non-English  
14 
 
criteria. A further two studies (PhD Thesis) were excluded because full text versions 
of the research were unavailable. Full texts of the remaining 37 articles were then 
examined for inclusion.  Following full text screening, 28 articles were removed for 
failing to meet eligibility criteria. This resulted in a total of 9 articles for systematic 
review. An additional 2 studies were incorporated into the review following hand-
searching reference lists of relevant articles, leading to a total of 11 papers for 
review.  
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Figure 1. ‘Preferred Reporting Items for Systematic Reviews and Meta-Analyses’ 
(PRISMA) diagram (Moher, Liberati, Tetzlaff, Altman, & Group, 2009) 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Records identified through 
database searching in 
November 2017 (N = 508)  
 
AMED n= 2 
CINAHL n = 96 
PsychINFO n = 108 
MEDLINE n = 301 
SCOPUS n = 1 
 
Records after duplicates removed           
(N = 460)               
Additional records identified 
from searching in March 2018 
(N = 26) 
PsychINFO n = 24 
Medline n = 2 
 
Records Screened              
(n = 460) 
Full text articles 
assessed for eligibility 
(n = 37) 
Studies included in qualitative synthesis 
 (n = 9) 
Additional studies included following searches of the 
reference lists of included articles  
(n = 2) 
Total Included (N = 11) 
Records Excluded (n = 423) 
 
Not research involving people at 
risk of HD = 60 
Not original qualitative research 
= 143 
Not research in the English 
language = 9 
Research exploring alternative 
health conditions = 195 
Research before 1993 = 4 
Research involving participants 
under the age of 18 = 5 
Full text articles excluded   
(n = 28) 
Not research involving people at 
risk of HD = 3 
Research not exploring 
experiences of predictive genetic 
testing = 13 
Research involving participants 
under the age of 18 = 4 
Not original qualitative research = 
5 
Research exploring alternative 
health conditions = 3 
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1.2.4. Quality Appraisal 
On completion of the systematic search process, studies selected for inclusion were 
assessed using a quality assessment framework (Critical Appraisal Skills Programme 
- CASP, 2017).  The CASP Qualitative Checklist was developed in partnership with 
Better Value Healthcare Ltd (BVHC), which was set up to promote good practice of 
value-based healthcare (CASP, 2017). The CASP was specifically developed for use 
in systematic reviews and can assist in assessing the quality of original research 
articles (Hannes, Lockwood, & Pearson, 2010). The CASP is one of the most ‘user-
friendly’ and ‘widely used’ quality assessment tools (Verboom, Montgomery, & 
Bennett, 2016). However, in a comparative assessment of three popular quality 
assessment tools, the CASP’s sensitivity to descriptive, interpretive and theoretical 
validity was questioned (Hannes, Lockwood, & Pearson, 2010). In order to address 
these limitations, this project has utilised an augmented version of the CASP, which 
includes four items adapted from the Joanna Briggs Institute Qualitative Assessment 
and Review Instrument (The Joanna Briggs Institute, 2014). The adapted CASP 
instrument (Appendix C) has been used in previous research by Verboom, 
Montgomery, and Bennett (2016) with good effect, and contains 12 items, all of 
which can be answered with either ‘Yes’, ‘No’, or ‘Unclear’.  
 
Further adaption of the marking criteria was required to permit calculation of inter-
rater reliability for individual studies. Each item was scored 1 for ‘No’, 2 for 
‘Unclear’ and 3 for ‘Yes’. These adaptions were implemented to aid cross checking 
amongst reviewers and are not designed to yield an overall numerical ‘score’ for the 
methodological quality of studies. Rather, the questions listed within this framework 
are designed as prompts to guide reviewers in a critical analysis. As there is no 
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consensus on the relative weight each characteristic of a study has on overall quality, 
the presentation of a simple summed score would risk being more misleading than 
informative (Verboom, Montgomery, & Bennett, 2016).  
 
1.2.4.1 Outcome of quality assessment   
To enhance the reliability of the quality assessment, an additional researcher rated 6 
out of the 11 articles independently against the same quality criteria. An inter-rater 
reliability analysis using the Kappa a coefficient was performed (Cohen, 1960). 
These ranged from 0.66-1.00 for each of the six studies, while the overall Kappa 
score was 0.86 (p < .0001), indicating good inter-rater reliability (Appendix D). 
 
Given the wide variety of quality assessment tools available, together with the lack 
of coherence about assessment criteria, no studies were excluded due to 
methodological quality. Overall, the aim and purpose of the articles included in the 
review were well stated, as was their chosen methodological design. Results were 
generally well reported and often justified with the use of quotations. The majority of 
studies reported sufficient information relating to approach to data analysis and 
information relating to data collection was generally well specified. However, 
reporting of patient demographics were less consistent, as were descriptions of 
researchers’ epistemological position and framework. Furthermore, reflexivity 
tended to be inadequately reported, as is common within empirical research (Walsh 
& Downe, 2006).   
 
1.2.5. Study characteristics  
A summary of the 11 studies included in this review is provided in Table 1.4. The 
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studies had a variety of aims, but all led to findings relating to people’s experiences 
of predictive genetic testing for HD. Ten studies collected data via face-to-face 
interviews and one study used telephone interviews, providing a cohesive method of 
data collection methods throughout the sample.  
 
There were variations in the reporting of participant demographics. Not all studies 
reported the age of individual participants; the age range of those that did was 
between 18 to 74. Given that the population within all the studies accounts for adults 
across the life span, concerns relating to the transferability of the findings to different 
age groups should be limited. All studies apart from the case studies used both male 
and female participants.  Four of the studies were conducted in the United States, 
three in Sweden, two in the United Kingdom, one in Australia and one used 
participants from both Canada and the United States. Additional information is 
provided in Table 1.4.   
 
In relation to data analysis, a range of methods were employed. Two studies used 
Interpretive Phenomenological Analysis, two used content analysis, whilst a further 
two studies used a descriptive case study approach. One study utilised grounded 
theory, and one used thematic analysis. One project combined grounded theory and 
thematic analysis, and one used narrative enquiry. One study’s method of analysis 
was unclear, suggesting data was analysed in accordance with conventions of 
qualitative data analysis
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Table 1.4 Summary of included studies  
Author/Date Country  Study Aim Method  of 
Analysis 
Sample 
population 
Method of data 
collection 
Key 
Themes/Findings 
Quality 
Assessment 
Score 
Andersson et al, 
2013 
 
 
Sweden  To describe the 
experiences of 
undergoing a 
presymptomatic 
genetic test for HD 
Case study  18 interviews with 
an “at risk” female 
and her partner 
covering a period 
of 15 months 
Recurrent 
Interviews  
Findings revealed 
several themes 
including, reasons for 
testing, waiting for 
the outcome, issues 
with disclosure, 
facing the future and 
trying to adapt   
31/36 
(Kappa = 0.66) 
Andersson et al, 
2016 
 
 
 
 
 
 
Sweden  Describe a young 
couple’s long-term 
experiences and 
consequences of a 
predictive test result 
for Huntington’s 
disease 
Case study  18 interviews with 
an “at risk” female 
and her partner 
covering a period 
of 2.5 years 
Recurrent 
interviews and 
informal 
conversations  
Variety of long-term 
consequences, 
characterised by 
anxiety, repeated 
suicide attempts, 
financial difficulties 
and divorce. 
28/36 
Chapman, 2002 United 
Kingdom  
To retrospectively 
explore the views  
of people affected 
by HD and to assess 
the impact of a 
positive predictive 
test result 
IPA 21 adults (11 male 
and 10 female) 
aged between 19-
60 years 
Semi-Structured 
Interviews  
A number of key 
themes were 
identified and 
included the age of 
testing; the 
implications of living 
with the knowledge 
of gene status; and 
the potential impact 
on future 
reproductive issues.  
 
27/36 
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Cox & McKellin, 
1999 
Canada  To explore the 
social meanings and 
lived experiences of 
people undergoing 
predictive testing 
for Huntington’s 
Disease.  
Thematic Analysis  22 adults (7 males 
and 15 females) at 
risk of developing 
HD and 41 family 
members.  
Semi-structured 
Interviews  
Results found a 
number of social, 
biographical and 
temporal factors that 
families consider 
when discussing risk 
and its modification 
through predictive 
genetic testing.  
26/36 
(Kappa = 0.86) 
Gong et al, 2016 USA Explore how the 
knowledge of 
Huntington’s 
Disease gene-
positive status 
influences pre-
symptomatic young 
adults  
Combination of 
grounded theory 
and thematic 
analysis 
14 young adults 
(12 female and 2 
male) aged 
between 18-35 
years  
Semi-Structured 
Interviews  
Knowing one’s gene-
positive status result 
can promote positive 
changes in 
individuals approach 
to life. However, 
results were also 
shown to impact on 
career choices, 
romantic 
relationships and 
family planning 
31/36 
(Kappa = 0.68) 
Hagberg et al, 
2011 
 
 
 
 
 
 
 
Sweden  To explore the long 
term (>5 years) 
experiences of 
being a mutation 
carrier for 
Huntington’s 
Disease  
Content 
Analysis 
10 adults (4 male 
and 6 female) aged 
between 34-62 
years 
Semi-Structured 
Interviews  
Five main themes 
and 14 sub-themes 
emerged from the 
interviews that 
reflected the lived 
experiences of being 
a mutation carrier up 
to a decade after 
receiving the test 
result. Positive 
changes included a 
greater appreciation 
of life and closer 
family relationships. 
27/36 
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On the other hand, 
decisional regrets 
and negative impacts 
were reported.  
Schwartz, 2010  USA To explore the 
meaning of being 
diagnosed with 
Huntington’s 
Disease  
Narrative inquiry  10 adults (3 males 
and 7 females) 
aged between 20-
74 years 
Semi-structured 
interviews  
Several 
psychological 
implications were 
found. Analysis 
yielded four main 
themes; the 
discovery of HD, 
conformation of gene 
status, disclosure and 
living with the 
consequences  
27/36 
Sobel & Cowan, 
2003 
 
 
 
 
USA To examine the 
impact predictive 
genetic testing for 
Huntington Disease 
has on the family 
system   
Grounded Theory 18 families, 
comprising of 55 
individuals, who 
had been tested at 
least one-year 
prior to the study 
and were 
asymptomatic at 
the time (No 
further 
demographic 
information 
available) 
Semi-structured 
interviews. 
Predictive genetic 
testing was found to 
have an impact on a 
variety of areas 
including, role 
changes, family 
membership and 
cohesion, in addition 
to a number of 
changes in patterns 
of communication. 
29/36 
(Kappa = 0.86) 
Taylor, 2004  Australia  To explore 
predictive test 
decision-making by 
individuals at risk 
for Huntington’s 
Disease  
Unclear – “in 
accordance with 
conventions of 
qualitative data 
analysis” 
16 adults (7 males 
and 9 females) 
aged between 20 -
60 years 
Semi-Structured 
Interviews  
Findings suggested 
predictive testing 
was regarded as a 
significant life 
decision and had 
important 
implications for self 
28/36 
(Kappa = 0.87) 
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and others, including 
family planning and 
preparing for the 
future.  
Theed et al, 2017   
 
 
 
United 
Kingdom  
Investigate how 
people who tested 
positive 
Huntington’s 
disease understood 
and experienced 
psychological 
distress and their 
expectations of 
psychological 
therapy 
IPA 9 adults (4 males 
and 5 females) 
aged between 24 
and 56 years 
Semi-structured 
Interviews  
Three superordinate 
themes: attributing 
psychological 
distress to HD, 
changes in 
attributions of 
distress over time, 
and approaching 
therapy with an open 
mind. 
30/36 
(Kappa = 1.00) 
Williams et al, 
1999 
 
 
 
 
USA To describe the 
expectations of 
those seeking 
presymptomatic 
gene testing for 
Huntington disease 
Content analysis  17 adults (11 
female and six 
male) aged 
between 18-59 
years 
Semi-Structured 
Interviews  
Common themes 
included anticipating 
relief from 
uncertainty, hoping 
to plan for the future 
and wanting to know 
if their children were 
at risk of developing 
HD.  Results also 
spoke about of 
people anticipated 
loss of family 
support from 
relatives as well as 
venturing into the 
unknown, and 
planning for 
disclosure. 
30/36 
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1.2.6 Synthesis of the findings  
A meta-ethnographic approach was selected to integrate findings and arrive at an 
overall qualitative synthesis (Atkins et al., 2008; Noblit & Hare, 1988; Purc-
Stephenson, & Thrasher, 2010). Meta-ethnographic approaches are appropriate for 
integrating and interpreting qualitative data and are regularly used within health and 
social care research (Atkins et al., 2008). Some authors have questioned its use for 
combining findings of primary research, particularly those adopting different 
theoretical perspectives (Dixon-Woods, Shaw, Agarwal, & Smith, 2004). However, 
many argue the strength of this approach lies in its attempt to preserve interpretive 
properties of the original data. In relation to the current review, synthesis was guided 
by the model developed by Noblit and Hare (1988), listed in Appendix E.  
 
Papers were read and re-read to become familiar with content and detail of the 
studies and to begin the process of obtaining 'metaphors' or emerging themes from 
each of the 11 studies. Data from all studies was extracted by the lead researcher. To 
reduce potential bias, data was also extracted from a selection of studies by an 
additional researcher and compared, with no significant differences being revealed.  
 
Given the number of themes reported and different research designs, in line with 
other meta-ethnographies (e.g. Atkins et al., 2008; Purc-Stephenson & Thrasher, 
2010); a thematic analysis was conducted on the key themes from each study. Each 
article was coded according to themes relating to the research question3. This was 
achieved by repeating rounds of analysis whereby the researcher arranged each 
                                                        
3 [What are the experiences and psychological implications of predictive genetic testing for HD in people at risk 
of developing the disease] 
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article in date order, comparing themes and concepts from paper 1 with those 
emerging from paper 2. The synthesis of these two papers were then compared and 
revised considering paper 3. The process was repeated until themes were revised on 
the basis of all 11 articles. Finally, the researcher developed meta-themes that 
provided an over-arching framework accounting for the findings generated from the 
original articles and incorporated the synthesis of themes produced by the analysis. 
A list of themes and meta-themes are listed in table 1.5.  
 
1.2.7 Reflexivity  
The author is male and has had exposure to Huntington’s disease within his family, 
with his maternal grandfather being diagnosed in 2014. It is acknowledged that these 
experiences may have influenced his interpretation of the findings from this review, 
and as such the above steps (i.e. inter-rater reliability and the use of an independent 
researcher to compare themes) were employed to try and reduce potential bias.  
 
1.3 Findings 
 
Three meta-themes were identified from the synthesis of 11 articles. These were 
‘Facing the truth’, ‘Living with the truth’ and ‘Sharing the truth’. Within each of the 
meta-themes, a chain of subthemes was developed. Table 1.5 identifies which meta-
themes, and subthemes, were considered within each of the articles.  
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Table 1.5 Meta-themes and Sub-themes ascertained in the systematic review  
Meta-themes                    Facing the truth            Living with the truth    Sharing the truth  
Sub-Themes  Uncovering 
Reality 
Striving for the truth -fact 
as a foundation? 
 
Adjusting to 
loss  
Re-establishing 
of self  
 Do they need 
to know? 
Can they handle 
knowing? 
 
Theed et al, 
2017   
         
Andersson et al, 
2016 
         
Gong et al, 
2016 
         
Andersson et al, 
2013 
         
Hagberg et al, 
2011 
         
Schwartz, 2010   
 
        
Taylor, 2004   
 
        
Sobel & 
Cowan, 2003 
         
Chapman, 2002  
 
        
Cox & 
McKellin, 1999 
         
Williams et al, 
1999 
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1.3.1. Facing the Truth  
This meta-theme represents information about how people come to acknowledge the 
presence of HD within their families, together with the implications this had on their 
decision to be tested. There were two subthemes: ‘Uncovering Reality’ and ‘Striving 
for the truth: Fact as a foundation?’ 
 
1.3.1.1 Uncovering Reality 
This subtheme arose from participants’ accounts of how they first discovered HD, 
together with their initial thoughts and reactions. Five articles discussed participants’ 
experiences of finding out about HD (Andersson et al., 2013; Schwartz, 2010; 
Taylor, 2004; Chapman, 2002; Cox & McKellin, 1999).  Schwartz (2010) reported 
how the discovery of HD often surfaced when participants became aware that 
something was ‘awry’ with a relative. For most, HD was a ‘new entity’, bringing 
about an array of emotions, including ‘shock’, ‘surprise’, ‘frustration’, ‘isolation’, 
and ‘relief’ (Schwartz, 2010 p.159). Furthermore, several of the participants’ stories 
alluded to the private nature of the disease.  
“It was a secret until I was an adult and my mother’s symptoms had already 
progressed” 
       (Schwartz, 2010, p.  4159) 
 
Reasons behind this enigmatic behaviour seem to be multifaceted, with Schwartz 
(2010) suggesting a range of potential explanations including: new mutations, 
paternity issues, early death of parents, late onset, or infrequent contact with 
extended family. Despite being a well reported study, with several participant 
                                                        
4 p refers to page number/s from which quotes were obtained  
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quotations, the small amount of information in relation to data analysis and the 
absence of any reporting on reflexivity by the author, raises concerns around the 
external validity of the results. However, Chapman (2002) with a much larger 
sample, reported similar findings, with participants confirming they were often not 
aware of HD until much later in life. 
“My mother died at 86. My father died at 79 both really in good health… 
we’d never heard of HD even when it came up” 
        (Chapman, 2002, p. 356) 
 
In contrast, Cox and McKellin (1999) spoke about how some people were aware of 
HD much earlier, suggesting that exposure to HD is variable across families, with 
some seeing the importance of sharing information from an early age.  
“we might have been 16 (pause) 17 . . . when we thought of it and saw that it 
was in the family” 
       (Cox & McKellin, 1999, p. 630) 
 
1.3.1.2 Striving for the truth: Fact as a foundation?  
It is important to establish what factors are associated with a person’s decision to 
undergo testing. This subtheme attempts to elicit people’s understanding of the 
testing process and personify the reasons contributing to such an important life 
choice.  
 
Many of the original themes within the articles selected for review are relevant here. 
There appears to be a distinct view that predictive testing offered an opportunity to 
gain significant life knowledge, and to allow people to prepare and make choices 
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about their future (Anderson et al., 2013; Taylor, 2004; Chapman, 2002; Williams et 
al., 1999).  
 
Anderson et al. (2013), start their narrative at the point where their participant made 
the decision to take the predictive genetic test. For the person in question, there was 
little consideration whether “it was right or wrong to take the test” or “what the 
consequences would be”, instead admitting the outcome was something “she just 
wanted to know” after her father became symptomatic. (Anderson et al., 2013,  p. 
192). Being a well recorded study, with effective use of participant quotes and a 
sound quality assessment score, findings can be interpreted with confidence. 
However, as case study, transferability of findings is limited.  
 
While the decision to get tested was less considered for some participants, others 
reported a much more cogitated approach. Williams et al. (1999), a well reported 
study, found that ‘at risk’ people sought testing to help make decisions about ‘health 
care needs’, ‘family’, ‘careers’ and ‘finances’ (Williams et al., 1999, p. 112), 
illustrated by an at-risk person who had just got married. 
“I just got married and I wanted to have my own kids ... and if I did have it, I 
wanted to start getting financially ready now instead of waiting.”  
       (Williams at el., 1999, p. 112) 
 
Despite concerns relating to research design and method of analysis, Taylor (2004) 
reported similar findings, suggesting predictive testing was perceived by all 
interviewees as an opportunity to acquire significant life information. Furthermore, 
given the accurate and factual nature of the result, testing was seen to provide a 
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foundation from which “subsequent life decisions can be made” (Taylor, 2004, p. 
140).    
“I’d like to know [my gene-status for HD] for a fact… you can’t plan 
anything on fairytales” 
        (Taylor, 2004, p. 140) 
 
In addition to making life choices while they remained healthy, people also spoke 
about how the knowledge of their gene status helped them make plans for when they 
would become unwell and may no longer be able to communicate their desires. One 
at risk person stated: 
“The biggest thing that scares me about all this is that I’m going to get to a 
point where I’m not able to take care of myself and my biggest fear is I’m 
going to get put into somebody’s hands that really doesn’t care what happens 
to me”  
       (Williams at el., 1999, p. 112) 
 
Chapman (2002) and Williams et al. (1999) also reported participants’ concerns 
around future generations, especially knowing their children’s risk and potential 
ramifications that has.  
“…if I have it both the boys will have to have the test, but if 1 don’t they 
won’t have to have it. If it is negative, the boys will have peace of mind, if it 
is positive then we will need serious counseling for my sons and 
grandchildren” 
(Williams at el., 1999, p. 112) 
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Another common theme reported by Chapman (2002) and Sobel and Cohen, (2003) 
was around familial pressure, with some at risk people reporting difficulties in 
coping with the uncertainty of potential gene status of at-risk family members.  
“When my sister tested positive, my family said I owed it to them to be tested 
so they might know that there was at least one who was okay.”  
       (Sobel & Cohen, 2003, p. 51) 
 
In addition to the themes identified above, research suggested that predictive genetic 
testing could offer some form of relief from the uncertainty associated with the 
disease. Williams et al. (1999) reported how for some, not knowing their gene status 
was extremely difficult, with the possibility that they would develop HD being a 
persistent thought.  
“I think it’s been probably the most stressful thing that I have ever gone 
through emotionally. It has made me question everything, from where I’m at 
in my career, to all of the choices I have ever made.” 
       (Williams et al., 1999, p. 111)   
 
Furthermore, predictive genetic testing seemed to offer an escape from constant self-
monitoring, with at risk people becoming preoccupied with potential symptoms and 
uncertainty over their gene status.  
“This summer, I had some muscle twitching and I guess I immediately 
thought this could be HD. So, that’s what brought me to testing, thinking 
perhaps that this was HD. It’s been a very difficult thing to think about, to 
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deal with. Part of this is just a sort of terrible anticipation, that’s kind of 
looming over you”  
       (Williams et al., 1999, p. 112)   
 
1.3.2. Living with the Truth  
Two meta-subthemes epitomised ‘Living with the Truth’: ‘Adjusting to loss’ and 
‘Re-establishing of self’. 
 
1.3.2.1. Adjusting to loss  
This subtheme relates to reported changes and the associated forfeiture following the 
outcome of predictive genetic testing, with several studies reporting changes in 
feelings, attitudes and thoughts about life (Theed et al., 2017; Gong et al., 2016; 
Hagberg et al., 2011; Schwartz, 2010; Chapman, 2002). Theed et al. (2017) reported 
how people often attributed psychological distress to HD following a positive test 
result, with participants believing the experience of physical and psychological 
difficulties was now ‘inevitable’.  
“Sometimes I depress myself because sometimes maybe I do think too far 
ahead...HD just affects so many aspects and that does scare me”  
        (Theed et al., 2017, p. 6) 
 
 
Receiving a positive test result also seemingly changed participants’ perceptions of 
their psychological difficulties, with people much more likely to attribute distress to 
the biological nature of HD.  
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“you’ve got something to blame it on now’… if you’re tired it’s because of 
the gene, you know, if you get annoyed it’s because of the gene” 
         (Theed et al., 2017, p. 7) 
 
Confirmation of gene status was also associated with a variety of difficult feelings.  
The research shows people often embark on the journey of predictive genetic testing 
in an attempt to gain some clarity and reduce the anxiety of not knowing their gene 
status.  
“I think I’d have been probably down and upset about it if I hadn’t have had 
the test and just sat in limbo not knowing” 
        (Theed et al., 2017, p. 6) 
 
However, confirmation of gene status did not always reduce anxiety. Positive test 
results seemed to replace one type of ambiguity with another (Theed et al., 2017), 
with participants reporting the uncertain nature of the disease was as anxiety 
provoking as not knowing they were gene positive.  
“No one can tell you what kind of symptoms you’re going to get. I suppose 
that makes you a bit anxious because you don’t know ...you’ll never know 
definitely ...it’s not a set path which is really hard” 
         (Theed et al., 2017, p. 6) 
 
This was further supported by Hagberg et al. (2011), who found for some people in 
their study, receiving the test results was much harder than anticipated.  
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“I was maybe a little too, a bit too optimistic/.../it has cost me more than 
what I thought it would” 
       (Hagberg et al., 2011, p. 73) 
 
A common theme across the research was the initial shock of a positive result, which 
often caused elevated levels of distress (Anderson et al., 2016; Anderson et al., 2013; 
Hagberg et al., 2011; Schwartz 2010; Sobel & Cohen, 2003). This seemed to be 
followed by a sense of panic and fear, as people started to process what this new 
discovery meant for them and their future. 
“if one hadn’t known then it would have been easier to put one’s head in the 
sand... it would at least have been 50%.../So it has affected me, and I am very 
scared/…/I am not like the person I used to be, I have changed” 
       (Hagberg et al., 2011, p. 73) 
 
The process of predictive genetic testing also seemed to impact people’s quality of 
life, with some reporting they could no longer enjoy life and others “struggling to 
identify anything positive about taking the test” (Hagberg et al., 2011, p. 73). 
Furthermore, a further three participants within the same sample reported feelings of 
regret ‘several years’ after testing (Hagberg et al., 2011, p. 73). In addition to a sense 
of hopelessness, feelings of isolation and a lack of peer support was also present for 
some people following the result (Gong et al., 2016), suggesting a loss of 
connectedness. 
 “It can be lonely to know you’re gene-positive” 
        (Gong et al., 2016, p. 1193) 
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The sense of loss associated with testing was not only apparent for the individuals at 
risk, several studies reported how test results often penetrated the wider family, with 
carriers and non-carriers reporting a sense of chaos and despair (Anderson et al., 
2016; Anderson et al., 2013; Taylor, 2005; Sobel & Cowen, 2003).  
 "If we hadn't been tested we wouldn’t be in this mess now,"  
        (Sobel & Cohen, 2003, p. 50) 
 
The impact of testing also appeared to affect people’s close relationships, as people 
tried to distance themselves from their diagnosis. Anderson et al. (2016), reported 
how for the person in their study, discovering their status sparked a catalogue of 
changes in a desperate attempt to escape HD.  
“It was a difficult time for me. I had left my family in the desperate search for 
a new life where Huntington’s had no part” 
        (Anderson et al., 2016, p. 569) 
 
Despite being a case study, findings reported by Anderson et al. (2016) are 
methodologically sound. Furthermore, both Chapman, (2002) and Gong et al. (2016) 
reported how being a mutation carrier influenced people’s relationships for a variety 
of reasons including the ‘fear of being alone when sick’ (Chapman, 2002, p. 74) or 
worries about other people accepting the consequences of the illness.  
“In a way, I feel like I can’t split up with my boyfriend, because I don’t feel 
like anybody else would want to be with someone, knowing that they’ve got 
HD” 
        (Gong et al., 2016, p. 1191) 
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Evidence of loss was not only associated with the immediate aftermath, but also 
appeared to impact people’s thoughts about the future. Gong et al. (2016) reported 
how the knowledge of gene status for some people in their study had made 
substantial life decisions like starting a family, more complicated. 
“Before I got tested, all I wanted was having kids. But now, whether it 
happens or not, I’m not gonna be upset either way. Because it’s a win-win 
situation, having kids or not having kids. Either I have kids and have that joy, 
or I don’t have kids and don’t have to put somebody else through that” 
       (Gong et al., 2016, p. 1192) 
 
For some, the loss associated with a positive test result was too difficult, with several 
papers reporting how for a number of people, suicide seemed like a ‘reasonable 
alternative to living a life of progressive disability’ (Schwartz, 2010, p. 161; 
Anderson et al., 2016; Sobel & Cohen, 2003).  
“And you know, suicide is something that I think about all of the time 
because it’s the way I’m going. I’m not going to a nursing home. So, I always 
have a plan” 
        (Schwartz, 2010, p. 161) 
 
1.3.2.2 Re-establishing of self  
This subtheme represents the process of change and restoration following predictive 
genetic testing. While the outcome of this process was fraught with challenges for 
some, other people across the research reported a greater appreciation of life 
following testing (Gong et al., 2016).  
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“I think I kind of live life differently. I try to enjoy life, live each day as if it’s 
the last day. … I just try to enjoy everything, take everything in and enjoy it”  
        (Gong et al., 2016, p. 1190) 
 
Scoring well on each of the quality assessment markers, with a good sample size, 
and clear data analysis and methods, results from the study can be interpreted with 
confidence. Moreover, Hagberg et al. (2010) despite the smaller sample size, also 
reported many people within their study (8 out of 10), talked about the positive 
aspects of testing, with one-person reporting: 
“I am going to have as much fun as I can for as long as I can/.../I have 
become happier and, or one appreciates life more” 
        (Hagberg et al., 2011, p. 74) 
 
In a similar vein, despite being a complex process, receiving a gene positive result 
appeared to prompt some people to make important reflections on life and their 
identity, whether that be in relation to the positive aspects, or the more undesirable 
factors associated with the disease. 
“I think, especially being quite young and getting a result, some of your kind 
of youthful intoxication and that just kind of goes. …. But I think I’ve been 
through a process of—almost like having a mid-life crisis, so I’ve had to sort 
out—say I’ve only got 10 years to live. Maybe I’ve got longer, you know. 
Maybe I haven’t. It’s kind of like a process of essentializing my life” 
       (Chapman, 2002, p. 358) 
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 This sense of reflection appeared to develop into a number of profound changes for 
many, changes that were closely linked to the theme ‘Urgency to reach milestones’, 
developed by Gong et al. (2016, p. 1190).  A number of people within the research 
spoke about how the limited number of ‘healthy years’ ignited a desire to expedite 
the attainment of many life goals, including education, work and starting a family. 
Similar findings were reported by Hagberg et al. (2002) who described how for some 
people in their research, testing had spurred them on to do things they have always 
wanted to do. 
“I actually started studying at university…when I got the test results it was 
like a push to make the best of my life” 
         (Chapman, 2002, p. 72) 
            1.3.3. Sharing the Truth 
Two meta-subthemes exemplified ‘Sharing the truth’: ‘Do they need to know?’ and 
‘Can they handle knowing?’ 
 
1.3.3.1 Do they need to know?  
This subtheme denotes people’s hesitation in disclosing their genetic status to others 
and is characterised by the theme ‘Deciding between privacy and openness – how 
much should we share’ developed by Anderson et al. (2013, p. 193). For some 
people sharing their story was a way for them to take back some control, rather than 
worrying what people would say ‘behind their back’.  
“I want no secrecy, I don’t want people talking about me behind my back. It 
feels better if I can tell everyone and give my own version. I remember how it 
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was with my father, with people talking behind his back when he behaved 
strangely” 
        (Anderson et al., 2013, p. 193) 
 
In contrast other people were hesitant to share information with others, through the 
fear of discrimination and not wanting to be judged.  
“You have to be careful with who you talk about it because, for example, if 
you tell somebody and an employer finds out, they can choose not to hire 
you. Or insurance companies can still - they are technically not allowed, it’s 
illegal - but they still discriminate against you” 
       (Gong et al., 2016, p. 1193) 
 
There was also a sense of disparity in relation to disclosing one’s status to close 
family and friends. While the majority of people shared a sense of responsibility in 
disclosing their status to loved ones (Gong et al., 2016; Anderson et al., 2013; 
Hagberg et al., 2011) others, especially those with younger children decided to take a 
more secretive position.  
“My children don’t know anything; I haven’t been able to tell them about it”  
        (Hagberg et al., 2011, p. 74) 
 
1.3.3.2 Can they handle knowing?  
This subtheme, while connected to the one above, explores in more detail the moral 
dilemmas apparent when considering disclosure.  Hagberg et al. (2011), recounted 
how for some, disclosing their genetic status was often accompanied with difficult 
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emotions such as guilt, with one person reporting her son’s risk being much ‘harder 
to cope with, than her own’ (Hagberg et al., 2011, p. 75). Furthermore, there was a 
sense that by disclosing this information, parents may be somehow limiting the lives 
of their children by adding a burden and complexity that would be difficult to 
manage.  
“And I have thought about if I had gotten to know all of this when I was 
young, then how would I have felt about having [children]?/.../Somewhere in 
it all I would have felt limited/.../Let them have children if they want, all in 
their time, sooner or later they will find out about this anyways and then I 
can tell them” 
       (Hagberg et al., 2011, p. 74-75) 
 
Williams et al. (1999), on the other hand reported how children at risk of developing 
the disease from a parent also shared similar worries, not wanting them to feel guilty 
about their own fate.  
“My brother and sister and I have decided we’re going to tell Dad that our 
results are negative no matter what they are, because we don’t think he could 
handle thinking that he gave that to one of his kids” 
       (Williams et al., 1999, p. 112) 
 
Finally, the thoughts around disclosure and its effects, also appeared to be 
represented in thoughts about future relationships, with concerns about how or if a 
potential intimate partner will deal with such information.  
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“The biggest question is when or if or how do I tell someone that I want to 
date about Huntington’s disease and being tested. … just in general telling 
people, it’s very tough, because you don’t know whether they are going to 
judge you, and how they are going to react” 
       (Gong et al., 2016, p. 1193) 
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1.4 Discussion 
 
This aim of this systematic review was to produce a meta- ethnographic synthesis of 
qualitative findings relating to people’s lived experiences of predictive genetic 
testing for HD. A total of 11 articles were included, and analysis led to the 
development of three meta-themes, ‘Facing the truth’, ‘Living with the truth’ and 
‘Sharing the truth’. There were commonalities within the articles, indicating, at least 
in part, a ‘reciprocal translation’ (Atkins et al., 2008; Purc-Stephenson & Thrasher, 
2010). However, several dissonances were also present within the data, meaning it 
was not possible to provide a uniform account of people’s experiences.  
 
1.4.1 Summary of findings  
Despite variations in how people come to discover their risk of HD (Schwartz, 2010; 
Cox & McKellin, 1999), many appeared to view testing as an opportunity to gain 
significant life knowledge (Anderson et al., 2013; Taylor, 2004; Chapman, 2002; 
Williams et al., 1999). For some, testing provided a sense of relief from the 
ambiguity of not knowing and provided an escape from constant preoccupation with 
potential signs and symptoms (Williams et al., 1999).  
 
In terms of living with the knowledge of their gene status, a variety of responses 
were witnessed. Awareness of gene status appears to be linked to a direct change in 
beliefs, attitudes and thoughts. While some changes were associated with anxiety 
and worry, others were related to more positive aspects, especially in relation to 
outlook on life (Gong et al., 2016; Hagberg et al., 2011; Chapman, 2002). Testing 
seemed to provide an incentive to make the most of a limited number of ‘healthy’ 
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years, accumulating in sense of urgency to reach significant milestones. In contrast, 
some findings point to an awareness of gene status having a somewhat constraining 
effect, making relationship and reproductive decisions more difficult. The process of 
predictive genetic testing did appear to have a great emotional impact, with feelings 
of panic, shock, and fear permeating across studies (Anderson et al., 2016; Anderson 
et al., 2013; Hagberg et al., 2011; Schwartz 2010; Sobel & Cohen, 2003; Chapman, 
2002). Despite themes of tolerance and acceptance developing for some, others 
reported finding it difficult to accept the knowledge testing brought, resulting in a 
sense of hopelessness and isolation (Gong et al., 2016; Anderson et al., 2016; 
Anderson et al., 2013; Hagberg et al., 2011).  At its worst, knowledge of genetic 
status resulted in a sense of chaos and despair, with several people in various studies 
reporting pervasive suicidal thoughts, and suicide attempts (Anderson et al., 2016; 
Schwartz, 2010; Sobel & Cohen, 2003) 
 
1.4.2 Relation to previous literature  
Most research within this area consists of quantitative studies, reporting little or no 
significant psychological impact (Decruyenaere et al., 1996; Broadstock et al., 2000; 
Meiser & Dunn, 2000; Timman et al., 2004; Crozier et al., 2015). This review adds 
to our current knowledge by recounting a variety of qualitative papers reporting 
themes associated with distress and difficulty (Hayden & Bombard, 2005; Schwartz, 
2010; Hagberg et al., 2011). Furthermore, findings here highlight a variety of 
emotional responses, suggesting that standardised psychological measures of distress 
may not be sensitive enough to capture such experiences (Chapman, 2002; Hagberg 
et al., 2011; Crozier et al., 2015; Gong et al., 2016; Theed et al., 2017).  
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In relation to long term outcomes following testing, previous quantitative accounts 
have reported no significant lasting psychological impact (Timman et al., 2004). 
Akin to feelings associated with loss and adjustment by Kubler-Ross (1969), 
tolerance and acceptance did appear to develop for some people within this review. 
However, others reported finding it difficult to accept the knowledge testing had 
brought, resulting in a sense of hopelessness, isolation and in some cases suicidal 
ideation (Gong et al., 2016; Anderson et al., 2016; Anderson et al., 2013; Hagberg et 
al., 2011). 
 
The Common-Sense Model of self-regulation of health and illness developed by 
Leventhal et al. (1998) highlights how illness representations, or cognitions, are used 
to appraise the threat of disease in relation to its cause, controllability and 
consequence over time. Given the uncontrollable and fatal consequences associated 
with HD, the variety of reactions seen here are unsurprising, as it is likely that a 
diagnosis of the condition would be appraised as highly threatening and distressing. 
With this in mind, more contemporary models such as the Dual Process Model of 
grief developed by Stroebe & Schut (1999), may more accurately represent the 
complex and intertwining process of loss represented here.   
 
Despite the difficulties evident within the findings several studies reported some 
participants taking affirmative action’s following testing. This was largely in relation 
to outlook on life and a tendency to live life more in the moment, resulting in people 
seeking out experiences that they may not have prior to testing (Chapman, 2002; 
Hagberg et al., 2011; Gong et al., 2016).  
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1.4.3 Limitations  
This review focused on people’s experiences of predictive genetic testing within 
Western, English speaking countries. Whilst a variety of countries were included, 
and experiences appeared seemingly consistent, it is uncertain whether the current 
findings are transferable to other non-English speaking countries, given differences 
in beliefs, values and attitudes towards illness, together with potential divergences in 
access to healthcare and social support systems. 
 
Steps were taken to ensure a methodologically rigorous (e.g. consistent with other 
meta-ethnographies), transparent (e.g. by using appropriate quotations) and 
consistent (e.g. by making references to original themes) review was conducted. 
Search terms could have been expanded to include the term ‘Huntington’s Chorea’, a 
term that despite its age may have elicited further relevant research.    
 
To provide context to the analysis, the author’s subjective experiences of HD were 
made explicit (Walsh & Downe, 2006). However, as with many qualitative 
synthesises, it is likely that the results of the review were influenced by the author’s 
interpretations (Al-Natour, 2011; Shenton, 2004). As such, it would have been 
beneficial to have collaborated with co-authors for all articles during data extraction 
and analysis, to further enhance the validity of the interpretations.  
 
1.4.4 Clinical implications  
Several studies highlighted how the experience of testing resulted in significant 
emotional distress (Sobel & Cohen, 2003; Schwartz, 2010; Anderson et al., 2016). 
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While the impact of such knowledge is difficult to gauge, it is imperative that genetic 
counsellors have a good understanding of ego strength prior to the testing process. 
Furthermore, they must discuss the complex picture of what it is like to undergo 
predictive genetic testing and live with the knowledge of the outcome, as although 
results may provide certainty regarding status, uncertainties, particularly for those 
testing positive, are likely to remain. By highlighting a variety of experiences, the 
results of this review, may provide an insight into why the minority of people at risk 
of HD (<20%), decide to undergo testing. As such, previous findings (i.e. absence of 
significant psychological impact), may not accurately represent the full and complex 
picture. Given the findings of this review, it is difficult to recommend the continued 
use of standardised psychological measures to assess distress for clinical purposes. 
Alternatively, it may be beneficial for services to offer follow up genetic counselling 
and support to help monitor the effects of testing.  
 
1.4.5 Future research  
It would be useful to explore whether the results of this review are in line with 
people’s experiences from non-western countries. As such, future research could 
seek to conduct a review of literature exploring people’s experiences of predictive 
genetic testing for HD in varying geographical locations.  
 
Given the range of experiences witnessed within this review, further research 
exploring effectiveness of standardised psychological measures of distress compared 
to more specific measures for HD (e.g. Unified Huntington’s Disease Rating Scale - 
Witjes-Ané et al., 2002), would be beneficial. This could help inform future practice 
by producing a more accurate and coherent picture of potential psychological 
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consequences of testing.  
 
Finally, research exploring what factors and/or interventions might help facilitate 
adjustment to living with the knowledge of gene status, together with what may 
inhibit this, would help generate further understanding of people’s experiences of 
genetic testing for HD. 
 
1.5 Conclusion 
This was the first qualitative systematic review of the literature exploring people’s 
experiences of predictive genetic testing for HD.  While previous findings suggest 
little psychological impact, the majority of participants within this review, did report 
significant cognitive, emotional and behavioural changes. It is therefore important 
for healthcare professionals and genetic counsellors to be mindful of the potential 
implications of testing, together with possible pitfalls in the use of standardised 
measures of psychological distress with this population.  
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2.0 Abstract  
 
Aim: Being diagnosed with cancer can be a traumatic and life changing event at any 
life stage. However, receiving a diagnosis during adolescence and young adulthood 
carries extra significance given the complicated task of navigating a variety of 
milestones. There is currently a dearth of research exploring young people’s lived 
experiences of cancer in the UK. The present study aims to build on existing 
research by using IPA to explore the lived experiences of young people aged 
between 13-24 years. 
Method: An interpretative phenomenological analysis (IPA) was undertaken with 
six young people (13-24 years) with a recent diagnosis of cancer. Semi-structured 
interviews were audio recorded, transcribed and analysed in line with the IPA 
methodology.   
Results: Three superordinate themes emerged from the data: ‘A natural injustice’, 
‘Get Ready for battle: Cancer as an adversary to youth’ and ‘The upside down: A 
parallel universe’. 
Conclusions: Young people’s experiences of being diagnosed and treated for cancer 
are considered. Clinical and service implications, together with areas for future 
research are discussed.  
Keywords: Adolescence, Young adults, Young people, 13-24, diagnosis, treatment, 
cancer, Phenomenological, IPA 
 
Abstract word count: 174 
 
 
 
 
56 
 
 
2.1. Introduction 
 
2.1.1 Background  
Being diagnosed with cancer can be a traumatic and life changing event, with 
people’s beliefs about life, themselves, and their future often being challenged 
(Macmillan Cancer Support, 2006). Although the majority of cancer patients 
experience a common set of life disruptions (Rowland, 1990), theories of human 
development suggest the way in which people experience them will differ. Research 
has suggested that people can focus on different issues, attaching different levels of 
significance to different aspects of their experience depending on the age they were 
diagnosed (Zebrack, 2011). Furthermore, research has shown that receiving a 
diagnosis during adolescence and young adulthood carries extra significance given 
the complicated task of navigating a variety of emotional and developmental 
milestones (Corbeil, Laizner, Hunter, & Hutchison, 2009).  
 
2.1.2. Cancer in young people 
Every day in the United Kingdom, seven young people (13-24 years) receive a 
diagnosis of cancer (Teenagecancertrust.org, 2018), and with approximately 310 
deaths each year, it is the leading cause of death from disease for young people in the 
UK (Cancer Research UK, 2015). While definitions of adolescence and young adults 
vary, this research will focus on those aged 13-24 years, in line with the Teenage 
Cancer Trust’s classification.  Despite such a broad age range, there are few 
empirical studies exploring the subjective personal experience of young people 
during this time (Woodgate, 2005; Taylor, Gibson, & Franck, 2008). A meta-
synthesis published by Taylor, Pearce, Gibson, Fern, and Whelan (2013), found that 
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much of the research exploring young people’s experiences of cancer has focused on 
parental or caregivers’ perspectives, with very little qualitative data from the young 
people themselves. Furthermore, the relatively small amount of literature that has 
started to concentrate on the experiences of those affected, has sought young 
people’s views of hospital facilities, treatment environments, social support and 
coping strategies (Lockhart & Berard, 2001; Mulhall, Kelly, & Pearce, 2004; 
Cassano, Nagel, & O’Mara, 2008; Wicks & Mitchell, 2010).  
 
2.1.3 Adolescence and young adulthood   
Adolescence and young adulthood are arguably the most complex developmental 
stages in a person’s life and are often marked by a plethora of changes in social, 
cognitive and emotional development (Arnett, 2000). The transition from childhood 
to adulthood is often fraught with challenges, with adolescents and young adults 
facing a range of tasks including establishing personal identity, seceding from 
parents/caregivers, managing intensifying relationships with peers and/or partners, 
exploring sexuality and gender identity, together with navigating potential future 
decisions such as career, education and family (Eiser & Kuperberg, 2007). 
Consequently, cancer related issues such as untimely confrontation with 
impermanence and death, changes in physical appearance, increased dependence on 
caregivers, disruptions in social life and challenges in school and/or employment 
have been shown to be acutely distressing for young people (Albritton &, Bleye, 
2003; Shama, 2007).  
 
2.1.4 The impact of cancer on young people  
From the Platt Report examining the welfare of young people in hospital (Platt, 
1959), to more recent NICE guidance published to help improve outcomes for 
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children and young people with cancer (NICE, 2014), research and policy has begun 
to stipulate the unique position and needs of young people with cancer. A mixed 
method study by children’s charity CLIC Sargent (2017) used telephone and Skype 
interviews with five young people and gathered survey data from a further 149 to 
explore the implications of living with cancer as a young person. The majority of 
respondents (79%, n=119) reported their cancer diagnosis had an impact on their 
overall wellbeing, with 70% experiencing depression, and 99% reporting episodes of 
low mood. The study also highlighted how 90% of young people in the sample 
experienced anxiety, with 42% of those reporting panic attacks during treatment 
(CLIC Sargent, 2017).  
 
Grinyer (2007) examined the effect cancer had on the lives of 40 young people aged 
between 16-24, through a mixture of in depth qualitative interviews and written 
narratives. Data was analysed using a qualitative approach known as ‘transcendental 
realism’ (Miles & Huberman, 1994) and consists of three main components; data 
reduction, data display and conclusion drawing. Results found three key areas: the 
disruption of life trajectories, the loss of independence and the setting of care. Within 
these, several important aspects of young people’s lives were also shown to be 
affected, including education, careers, life plans, friendship networks, appearance, 
sexuality and fertility. Such findings have been further supported in work by Lewis, 
Somers, Smith and Kerridge (2013), who through the use of thematic analysis found 
young people’s development was often arrested by their cancer experience, 
increasing their dependency on parents and complicating the process of making new 
relationships and gaining autonomy.  
 
59 
 
2.1.5 Lived experiences of young people with cancer 
Hedstrom, Skolinb, and Essena (2004), investigated the lived experiences of 23 
young people with cancer in relation to: receiving a diagnosis, undergoing treatment 
and being admitted to hospital. Data was gathered using semi-structured interviews 
and analysed using content analysis. Findings demonstrated young people were 
subject to a range of distressing experiences including alienation from peers, altered 
physical appearance and coping with the possibility of dying. Positive experiences 
included relationships with staff and being well cared for. More recently a study by 
Gibson et al. (2016), sought to find more information about how young people 
experience cancer and its treatment. Longitudinal video diaries of 18 young people 
aged 11-25 were analysed using qualitative content analysis. Four main themes 
emerged: treatment and relenting side effects, rehabilitation and moving on with life, 
relapse and coming to terms with dying.  
 
2.1.6 Rationale  
The emergence of qualitative and mixed methods enquiry over the past ten years has 
provided some knowledge surrounding the impact a cancer diagnosis can have on the 
lives of young people. Recent reports by CLIC Sargent (2017) have highlighted the 
relationship between physical and mental health among this population, revealing 
most young people surveyed, experienced some form of mental health difficulties 
whilst undergoing treatment.  
 
However, given the majority of research has been gathered in conjunction with 
parents and healthcare professionals, there is an absence of subjective accounts from 
young people themselves. Furthermore, despite the use of qualitative methods such 
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as thematic and content analysis shedding light on common themes associated with 
young people’s experiences, they are singular in focus. Additionally, in the case of 
content analysis, themes are not explicitly taken from the data itself, but gathered in 
conjunction with predetermined structures which are placed on the data set prior to 
the investigation, thus limiting the scope of what can be explored (Elo & Kyngäs, 
2008). The current study therefore aims to fill these gaps by using Interpretative 
Phenomenological Analysis (IPA) to gain a detailed account of what it is like to live 
with cancer as a young person within the UK. By adopting this approach rather than 
qualitative methods seen in previous research, it is hoped that a more robust 
understanding of lived experiences will be generated.       
 
2.1.7 Research Aims 
Whilst literature exploring the impact of cancer on young people has increased, there 
is a dearth of research that examines young people’s lived experiences of cancer. The 
aim of this study is to build on existing research by using IPA to explore the lived 
experiences of young people aged between 13-24 years. To ensure a detailed and 
recent account of personal experience, this project will focus on individuals who 
have been diagnosed within the last 6-18 months. The study aims to address the 
following question: 
What are the lived experiences of young people (aged 13 to 24) who have recently 
been given a diagnosis of cancer? 
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2.2. Method 
2.2.1 Design  
2.2.1.1 Qualitative approaches  
Qualitative research is an ‘umbrella’ term used to describe a variety of approaches 
that adopt a social inquiry into the way people make sense of and interpret their 
world (Atkinson, Coffey, & Delamont, 2001). This study adopted a 
phenomenological approach to explore the lived experiences of cancer amongst 
young people. 
 
2.2.1.2 Interpretative Phenomenological Analysis 
This research used Interpretative Phenomenological Analysis (IPA; Smith, 1996; 
Smith, Flowers, & Larkin, 2009). IPA is “committed to the examination of how 
people make sense of their major life experiences” (Smith, Flowers, & Larkin, 2009, 
p. 1) and as such was consistent with the research aim. By recognising that every 
methodological stance can create reality as well as explain it, this approach positions 
participants as the experts of their own experiences, focusing on ensuring people’s 
experiences are expressed in their own terms, i.e. from participants’ frame of 
reference. Therefore, IPA endeavours to give voice and make sense of experiences, 
utilising a bottom-up approach that avoids creating theories (Larkin & Thompson, 
2011; Smith et al., 2009; Taylor & Bogdan, 1998). IPA also recognises the role of 
the researcher when collecting information, adopting the term ‘double hermeneutic’ 
to acknowledge how the researcher’s own views and or experiences may influence 
data analysis (Smith et al., 2009).  
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2.2.1.3 Researcher’s position  
Acknowledging the researcher’s position and recognising the challenges of 
remaining impartial and objective is fundamental in the validity of research. As such, 
author reflexivity is key (Harris, 1976; Smith, 1983). As Smith et al. (2009) assert, 
experiences are brought to the research; and the author’s identification as a white, 
middle-class male with a recent experience of cancer within their family, will 
somewhat impact the interpretation of the data. A bracketing interview was 
conducted in addition to measures of self-reflexivity (journal and interview logs) to 
consider the stance in which the author relates to and interprets experiences of 
difficulty and illness (Finlay, 2008).  Initial reflections included thoughts around 
resilience and the importance of being able to voice individual experiences 
regardless of age.  
 
The researcher utilized an interpretivist position. Interpretivists believe that society 
operates differently from the natural world and believe reality is subjective. This 
approach is less interested in universal meaning or commonality, but instead focuses 
on how a person develops their own unique views based on their individual 
experiences (Willis, 2007). Rather than measuring phenomena, interpretivist 
research attempts to gain an insight into what life is like for a person and is 
congruent with the researcher’s own personal epistemology.  
 
 2.2.2 Participants  
2.2.2.1 Inclusion and Exclusion Criteria 
Sample size within IPA research is often contextual. In line with guidance developed 
by Smith et al. (2009) and to reduce the risk of oversaturation of the data, a small 
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sample of participants was selected. To ensure homogeneity of the sample, the 
project enlisted a range of inclusion and exclusion criteria. Young people aged 
between 13-24 years were eligible to participate within this project, with people 
falling outside this age range being excluded. To ensure a recent account of personal 
experience, people between six and 18 months post-diagnosis and still undergoing 
treatment were included. Participants were excluded from the project if they were 
unable to speak English or had been identified by clinical staff as being too unwell to 
take part. To gain an insight into the lived experiences of this age range and given 
the lack of previous research, both male and female participants were included 
(Taylor et al., 2013). Table 2.1 provides a summary of the inclusion and exclusion 
criteria. 
 
Table 2.1 Inclusion and Exclusion Criteria  
Criteria  Inclusion   Exclusion  
Age  ≥ 13 Years - ≤ 24 Years < 13 Years - > 24 
Years 
Onset   ≥ 6 Months - ≤ 18 months  < 6 Months - > 18 
Months 
Gender Male/Female  n/a 
Language  English Non-English  
Stage Undergoing Treatment  Complete 
Remission/Palliative 
care regime  
 
2.2.2.2 Participant Characteristics  
Six young people participated in the study. Table 2.2 provides demographic 
information for the participants; pseudonyms have been used to ensure anonymity. 
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All participants were undergoing treatment when recruited.  Due to logistical reasons 
beyond the author’s control, the interview for one of the participants took place two 
weeks after their final treatment. The young person in question expressed a desire to 
still participate in the project and given the immediacy of their treatment completion 
it was felt their account would still be relevant and appropriate. One participant in 
the sample sadly died since taking part in the study. Given informed consent was 
obtained prior to their death, and in line with the Health Research Authority (HRA) 
guidance (See appendix G), their account has been included within this project. 
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 Table 2.2 Participant Characteristics  
Participant 
(pseudonym) 
Age Gender Date of diagnosis  Form of treatment  
Abigail  16 Female  February 2017 Chemotherapy 
Radiotherapy  
Adam  20 Male January 2017 Chemotherapy  
Radiotherapy  
Alesha  24 Female July 2016 Chemotherapy  
Surgery  
 
Claire  14 Female June 2017 Chemotherapy  
Surgery  
Jack  19 Male November 2016 Chemotherapy  
Surgery 
 
Joe 23 Male January 2017 Chemotherapy  
Stem Cell Treatment  
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2.2.3 Procedure  
2.2.3.1Ethical procedure 
Given the vulnerable nature of the people taking part in the study, due care and 
diligence to ethical standards were imperative. The research was first approved by 
Coventry University on 11th May 2017 (Appendix H), and further approval was 
granted by a National Health Service Ethics Committee, (REC reference; 
17/WM/0235) on 24th July 2017 (Appendix I). The project fully adhered to the 
British Psychological Society’s guidelines (BPS, 2010), recognising the importance 
of voluntary participation, assent and consent, as well as people’s rights to 
anonymity and confidentiality.  
 
2.2.3.2 Materials  
A semi-structured interview schedule was designed and utilised (Appendix J) in 
accordance to the guidance set out by Smith et al. (2009).  A semi-structured 
approach was selected as it provides guidance of the topic under investigation, whilst 
also ensuring a degree of flexibility for the participant and researcher, allowing other 
potentially salient experiences to be explored.   
 
2.2.3.3 Recruitment         
In recognition of the difficulty accessing the population due to their age and 
condition, this project utilised a purposive sampling method. Purposive sampling is a 
type of non-probability sampling that allows the researcher to select participants 
based on certain characteristics. On several occasions throughout the project the 
researcher met with the clinical team at two large regional cancer centres, one of 
which was based at a children’s hospital. During the recruitment period (September 
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2017 – February 2018), 22 participants were identified as eligible for participation.  
Participants and if necessary their parents/legal guardians were sent an information 
sheet (Appendix K, L, M) and were asked to contact the researcher or clinical team 
to express interest in taking part. A total of six young people agreed to be contacted 
by the researcher, all of whom agreed to take part.  
 
2.2.3.4 Interview Procedure      
Interviews took place between October 2017 and March 2018. The location of the 
interview varied and included the participants’ home (n = 3), university premises (n 
= 1) and the hospital (n = 2). Interviews lasted between 55 and 208 minutes (m = 96 
minutes) and were audio recorded. Participants were asked to review the information 
sheet again prior to starting the interview, following which assent/informed consent 
was obtained (See appendix N, O, P). Given the aim of the project, there was the 
potential that those involved may find participation distressing and or difficult. As a 
result, the option to take regular breaks, stop the interview or withdraw from the 
study at any point prior to data analysis was emphasised to participants. In addition, 
with the young person’s consent a letter detailing their involvement was sent to their 
GP. Time was allocated at the end of the interview for participants to reflect on the 
process of taking part. A debrief document containing information on local support 
services was also provided (Appendix Q). Participants were reminded that they had 
two weeks following the interview during which they could withdraw from the 
study, after which transcription and data analysis would be underway.  
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2.2.4 Analysis  
Following completion of the interviews, audio recorded interview data was 
transcribed as proposed by Smith et al. (2009), with identifying information being 
omitted or substituted as necessary. Following transcription, data was analysed in 
line with the procedure set out by Smith et al. (2009). Firstly, the researcher 
immersed themselves within the data set, by reading and rereading the first 
transcript. The second stage entitled “initial noting” examined semantic content and 
language within the data to produce a descriptive summary of the participant’s 
feelings and concerns. Data was then analysed in an interpretative way and the focus 
shifted to establishing meaning behind the words themselves. The researcher then 
used this information to develop a range of emergent themes within the data, which 
were then analysed for commonalities and relational aspects. The researcher then 
applied the above steps to the remaining transcripts before moving to the final stage, 
which involved identifying patterns and connections across the data as a whole. A 
detailed account of the IPA analysis procedure, examples of extracts from coded 
transcripts and a map of emergent and super ordinate themes can be found in 
Appendix R (Table 2.4), Appendix S and Appendix T respectively. Furthermore, the 
researcher maintained a reflective journal at each stage of the analysis in order to aid 
reflexivity.  
 
2.2.4.1 Validity and credibility  
Data authentication was achieved with a second member of the research team who 
assessed and commented on emerging themes. Validation of the final superordinate 
themes, content, linguistic and conceptual coding were also shared. Next, in order to 
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ensure sincerity of the findings, participants were contacted to ensure the outcome 
was an accurate and authentic representation of their account (Mays & Pope, 2000).  
 
 
2.3 Results 
 
Following the completion of data analysis, three superordinate themes emerged: ‘A 
natural injustice’, ‘Get ready for battle: Cancer as an adversary to youth’ and ‘The 
upside down: A parallel universe’. Within each superordinate theme lay several 
subordinate themes, see Table 2.3. Convergence and divergence amongst the 
narratives are considered throughout the results.  
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Table 2.3 Superordinate and subordinate themes   
  
 
 
 
 
 
 
 
 
 
Superordinate theme  Subordinate theme  
A Natural Injustice 1) Refuting the diagnosis: “I just didn’t 
believe them” 
 
2) “Why me”: Making sense of the 
senseless 
 
3) Incarceration: “You’re like kind of 
like stuck there” 
Get ready for battle: Cancer as an 
adversary to youth  
1) Arrested development  
 
2) A new perspective  
 
3) “The fight of the mind”: Me vs My 
Body 
The Upside Down: A Parallel Universe  
 
 
 
 
1) “Out of the loop” 
 
2) In your own world: “You don’t see 
girls with bald heads everywhere” 
 
3) Finding a safe harbour  
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2.3.1 A Natural Injustice  
All participants spoke to the invidious position of being diagnosed and treated for 
cancer. From battling disbelief to trying to make sense of this cruel and unapologetic 
disease, most young people reflected on the iniquitous and untimely task of being 
diagnosed with cancer as a young person. This superordinate theme consists of three 
subordinate themes, ‘Refuting the diagnosis: “I just didn’t believe them”’, “Why me”: 
‘Making sense of the senseless’ and ‘Incarceration: “You’re like kind of like stuck 
there”’.  
 
2.3.1.1 Refuting the diagnosis: “I just didn’t believe them” 
Four participants reflected on their experiences of struggling to come to terms with 
having cancer. This often emerged soon after the diagnosis and was intensified by 
the initial shock of receiving the news.   
“I just didn't believe them, I just said straight to them, I just said to them, my 
first words was you’re lying, you're lying to me” 
       
        (Joe, 216-2195) 
 
Joe described his initial disbelief when he was told he had cancer. Describing how he 
started “punching the bed” because he couldn’t comprehend what was happening 
demonstrates the level of anger and frustration he felt within this moment. Abigail 
also reflected on how being confronted with her diagnosis was extremely difficult, 
recalling how she “did almost faint” when the doctor told her she had cancer.  
 
                                                        
5 Lines numbers within transcript 
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This sense of disbelief and refutation was not static, instead reoccurring over the 
course of most young people’s cancer journey. Alesha, Joe and Abigail reflected on 
how difficult it was to come to terms with what the diagnosis now meant for them 
and their lives. This was often compounded by their expectations of “being a cancer 
patient” through what they had learnt via their own individual experiences and what 
they had seen within the media. Alesha spoke about how cancer was often portrayed 
as “something scary’ and “dangerous” and how it was hard to accept that she will 
now be “going through it” herself. Abigail also reflected on images she saw of 
cancer patients with “bald heads” and “looking all poorly”, which left her with a 
sense of worry and disbelief demonstrated by her use of the phase “oh my god, that’s 
me now”.  
 
Conversely, Adam, Jack and Claire did not report the same emotional intensity in 
their reactions, but instead reflected on how they employed distraction as a way of 
minimising or refuting what was happening. An example of which came from Claire 
who described how she went home and started reading a new book following her 
appointment:  
            “I had only just started reading the book, so I just sort of went straight  
into the book and sort of forgot about it”  
        (Claire, 128-129) 
 
The difficulty in coming to terms with a diagnosis of cancer is emphasised here with 
Claire trying to lose herself in her book and forget about the current situation. 
Diverting her attention suggests a possible need to take stock of the situation, 
confirmed by her statement “I think it might have been a distraction”. 
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2.3.1.2 “Why me?” Making sense of the senseless  
Several participants reflected on the unjust nature of being diagnosed with cancer, 
expressing difficulty in understanding their diagnosis. This was often accompanied 
by feelings of frustration and an ardent desire to try and make sense of their 
situation. For example, Alesha talked of how she was frequently consumed by the 
thought that she “did something wrong” and that somehow her diagnosis was a form 
of “karma” coming back to her. Similarly, Joe reflected on his past life decisions, 
wondering if previous actions had contributed to his current situation, “I’d go out 
and drink every weekend, and at the start I thought that might have been a reason 
why I was in here”. In contrast, Claire spoke about how she tried to remind herself 
that cancer is a disease that can happen to anyone, “I just sort of, just kept telling 
myself it happens to a lot of people”. 
 
In addition to self-attribution, Alesha and Joe questioned the fairness of their 
diagnosis, struggling to accept their position at this stage in their life. For Alesha, the 
difficulty lay in the fact she had just got married and had a child, “why did I get this 
chance to give birth and to get married and then all this happen”. Joe expressed an 
anger and frustration towards his position, questioning why he was having to live 
with this disease when other people didn’t.  
“I thought like, why me (pause) like there's people out there (crying) ok I not 
sure know if you want to hear it on here, but do drugs, do drugs every day, 
do things out of the ordinary, why haven't they got it” 
        (Joe, 641-645) 
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In contrast, the remaining participants did not express such concerns, instead 
alluding to how the diagnosis offered a form of relief by providing them with a sense 
of certainty. Jack spoke about how for him, confirmation of his tumour allowed him 
to make sense of his ongoing difficulties, which up until that point were perplexing:  
“I was… I was glad to know what it was to be fair… because that meant that 
I am gonna… were gonna be able to try and sort it”   
               (Jack, 285-287) 
 
Many participants spoke about their desire to understand more about their condition 
and treatment. This zealous attitude was often linked to a sense of mastery and 
seemed to provide a way for young people to try and take control of and engage with 
their condition:  
“Obviously, I had a look at what it was, because they told me I can't 
remember what the name of it was, but I had a look at what that was and like 
how long it would take to go through all the treatment” 
        (Adam, 207-211) 
 
Conversely, some young people took a more secondary approach putting their faith 
in the medical team and treatment. For example, Joe expressed his desire not to 
know about his current position and treatment options, stating “not knowing the 
result means that there might be a chance”. This was supported by Claire, who 
despite being “worried” about the chemotherapy, just wanted to “get on with it”.  
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2.3.1.3 Incarceration: “You’re like kind of like stuck there” 
Whilst the young people consented to treatment, the effects of being subject to such 
lengthy and at times “harsh” regimens was something that they all denoted as 
“difficult”. Abigail described how she was “forcibly” taken away from her normal 
life, while Adam, Claire and Jack expressed how they were “shocked” by the length 
of treatment, “having” to stay away from home for prolonged periods. Such 
restrictions lead to many young people experiencing a loss of freedom, akin to 
incarceration, as epitomised in Jack’s observation: 
“I don’t want to call it like a prison because it’s not……. But it kind of is... 
you’re like kind of like stuck there... you can’t just say I am going out… I’m 
going up town…”  
       (Jack, 1329-1335) 
 
Another striking observation that demonstrated the restrictive nature of cancer 
treatment came from Joe, who was often confined to the boundaries of the hospital 
during treatment: 
“they said if I was to go outside and get a cold I could die, you know no 
second chance like, that's why I have to stay in here…” 
        (Joe, 368-371) 
 
In addition to the constraints of the hospital environment, many of the young people 
explained how their home lives were also impacted because of treatment. Such 
reflections were often accompanied by feelings of antipathy and frustration, with 
several young people speaking to the sadness such restrictions inflicted on their 
lives. Alesha spoke about how she would constantly get “infections” which resulted 
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in her spending more time in hospital away from her son. Joe emotionally described 
how his treatment had stripped away previous life pleasures, commenting on how he 
was no longer “allowed” takeaways, and instead relied on a restricted diet due to the 
risks of “food poisoning”.  In addition to risks to their physical health, treatment also 
restricted the behaviours of many participants. Joe spoke about how he could no 
longer “go out” as he did not have the “strength”, while Alesha commented on how 
treatment meant she could no longer “breastfeed” her son, leading her to question 
her identity as a mother.  
 
This sense of constraint and confinement also seemed to penetrate the simplest of 
events such as spending time with friends, demonstrated here through Claire’s 
emotional account of a recent visit to her friend’s house:  
“I went over to ***** house, and they went out in the snow and things. That 
was very upsetting, cos I love the snow.  And this year it came, I couldn't go 
out in it” 
         (Claire, 707-710) 
 
Conversely, Adam took a more stoic approach when talking about his experiences. 
Describing how spending increased amounts of time on his “own” was part of the 
treatment and something he had come to accept. 
 
2.3.2. Get ready for battle: Cancer as an adversary to youth 
All participants reflected on how their experiences of cancer often felt like an 
internal and, at, time’s external ‘battle’. Participants spoke to a range of inherent 
challenges associated with living with cancer as a young person, from navigating the 
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course of treatment, to trying to uphold a sense of self that remained separate from 
the disease and protected their identity as a young person. This superordinate theme 
includes three subordinate themes, ‘Arrested Development, ‘A new perspective’, and 
‘“The fight of the mind”: Me vs My Body’.  
 
2.3.2.1 Arrested development  
Many of the participants discussed the impact of receiving a cancer diagnosis at such 
a crucial developmental stage: speaking to the loss of her newly established 
“independent” self, Abigail explains how cancer had made her more reliant on other 
people:   
“I was kind of drifting away a little bit, going to my friends and kind of 
gaining independence and doing things by myself, but like because I couldn’t 
do anything by myself, I had to rely on family…” 
       (Abigail, 714-717) 
 
Age was something that all participants connected with, however for the two older 
people in the sample, returning to a more dependent state often had implications for 
their partners, as well as their wider family. Losses here were linked to young 
people’s identity as partners and parents, highlighted by Alesha.  
“so basically, he was like the mother to our son... it was really 
 hard for me” 
         (Alesha, 103) 
 
In addition to the loss of new found independence, living with cancer as a young 
person had other unique consequences. Many of the participants here reflected on 
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how their cancer diagnosis forced them to start engaging in more matured and often 
complicated life decisions, they had not previously contemplated. Claire, the 
youngest person in the sample spoke about how her diagnosis meant she had to 
“grow up” and make decisions “you didn’t think you’d have to make”, which 
reached a crescendo when she chose to have an ovariectomy. 
   “I talked to Mum about it.  I don't want children but then it's the option if I  
want them when I’m older.  It's not something you think about at my age” 
        (Claire, 669-671) 
 
In addition to more practical life choices, young people reported how being 
diagnosed with cancer lead them to consider more existential events, such as 
impermanence and death, epitomised here by Abigail’s reflections:            
“I went to my friend’s funeral that passed away, so also that kind of set  
something off, something I need to think about, and watching like her friends 
carry on with life without her, is that going to happen to me, is that going to, 
yeah its quite like a lot to think about” 
(Abigail, 672-678) 
 
Although difficult to consider, Abigail’s reflections epitomise one of the most feared 
consequences of being diagnosed with cancer. This expression also highlights how 
for Abigail, the thought of life carrying on without her was quite “overwhelming”.  
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2.3.2.2. A new perspective 
In addition to delaying aspects of development, implications of a cancer diagnosis at 
this age were linked to a change in young people’s perspectives and outlook on life.  
Many of the young people spoke about how their view on life, and what was 
important had changed. For Joe this resulted in an ardent desire to start making more 
“memories”, while Abigail spoke about the desire to travel and experience more 
things.  
“I guess like travelling maybe, I don’t know, saying that I have achieved 
things like kind of, like, I think I am a lot more, like experiences are a lot 
more valuable than possessions” 
 (Abigail, 838-840) 
 
Another distinctive concept of living with cancer as a young person emerged from 
the participants shift in understanding and appreciation of ‘life’.  Stories from the 
young people suggested a new found responsibility to live life, and be appreciative 
for the time they had. For Jack, cancer made him “more grateful for life” leading 
him to take his time on earth “a lot more seriously”. Such growth and discovery was 
echoed by Claire, whose experiences resulted in the creation of a “bucket list” to 
help her focus on the things she felt were most important.  
 
Whilst these changes may have provided a sense of growth and mastery for some 
young people in the sample, reflections were not always positive. Depictions 
indicating the costs of such an early evolution were scattered throughout the 
narrative, with young people talking about an expedited coming of age that limited 
their number of “younger” years, as exemplified here by Joe’s statement: 
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“Yeah, I feel like I'm in a 23-year-old body, but I've got a 50-year-old brain 
do you know what I'm trying to say?” 
(Joe, 615-617) 
 
With a crack in his voice, and a depleted look on his face, Joe’s statement highlights 
how despite affording a new found perspective, cancer can drag young people into a 
development stage far beyond their years, forcing a responsibility and sensibleness 
whist eliminating the naive and unworldly innocence of this life stage.  
 
2.3.2.3 “The fight of the mind”: Me vs My Body 
Deep within the narratives shared by each young person lay a declaration to “fight” 
and overcome their condition. Inherent to this encounter was the notion that cancer 
was something that was separate to them, with many participants referring to how 
their mind was OK, but their body was not.  
“my body was saying something else...I had tubes everywhere...machines 
everywhere my body was not fine...but my mind was fine...” 
(Alesha, 442-445) 
 
This sense of splitting seemed to protect the young people’s sense of self, allowing 
some distance from them and the cancer. Furthermore, adopting this mind set 
seemed to increase their sense of control and omnipotence in what was often an 
uncertain and uncontrollable situation, as typified here by Abigail: 
“I wanted to gain some of that control back…because everything else was so 
uncontrollable” 
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(Abigail, 695-698) 
 
The importance of adopting a positive and optimistic mindset during treatment was 
also something shared by all the young people. Jack spoke about the importance of 
not looking at the “worst bits”, instead focusing on what “positive” you can take 
from the situation. Joe also spoke about the importance of having “positive 
thoughts”, which for him served to sustain a sense of “hope” about the future. 
Further to changing her “mind” and focusing on “seeing the positive”, Alesha spoke 
about the importance of surrounding herself with “positive people” who have “seen 
other people going through it” in order to help “encourage” her to keep going.  
 
For most young people, adopting a more encouraging mindset was vital to help them 
move forward. Furthermore, several participants spoke about how this shift in 
perspective came from within, personifying a resilience and strength that was 
integral to their identity as a young person.   
 
2.3.3 The upside down: A parallel universe 
This superordinate theme speaks to the unique experiences the young people 
underwent as a result of being a “cancer patient”. It encompasses a felt sense of 
being transported in to a new world, which at times led participants to feel separate 
from those around them. Three subordinate themes are discussed: ‘Out of the loop’, 
‘In your own world: “You don’t see girls with bald heads everywhere’” and 
‘Finding a safe harbour’.  
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2.3.3.1 ‘Out of the loop’ 
A striking theme seen within many of the young people’s stories was in relation to 
feeling somewhat disconnected from their friends. Abigail highlights this when she 
considers her relationship with her peers:  
“I was kind of like forcibly, like it was out of their control and it was out of 
mine, but I was kind of taken out of the loop by not being at school…I’d lost 
a lot of friends” 
       (Abigail, 537-540) 
Reflecting on why this disconnect may have occurred, Abigail explained how she 
would often sense apprehension in her peers, which she believed was a result of 
people “not knowing what to say”. This was supported by Joe who spoke about how 
certain people in his social circle didn’t “know how to talk about it”, resulting in him 
feeling disconnected and less confident: 
“You just think like, it knocks you down a little bit, because you think 
like, how can I explain, I'm still me, but they can't see that” 
(Joe, 717-719) 
 
Conversely, Jack and Adam spoke about how they chose to distance themselves 
from their friends whilst in hospital. For Jack, this position came from him not 
wanting other people to see him when he was so unwell, while Adam did not want 
people to act differently or “make a big deal out of it”: 
“Probably just did not want them to see me constantly sick or in that 
position… I don’t know...that’s just me” 
(Jack, 607-608) 
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In contrast, Claire spoke about how for her maintaining friendships were important. 
Highlighting the desire most young people shared, Claire reflects how being treated 
the same whilst undergoing treatment is vital, demonstrated here by her reflections 
of other people she had meet through treatment:  
“…they don't speak to their friends anymore, and they treat them differently 
like they're ill. My friends don’t, they still roll on the floor and do stupid 
stuff” 
(Claire, 438-440) 
 
2.3.3.2 ‘In your own world: “You don’t see girls with bald heads everywhere”’ 
This theme voices the participants reflections of how being diagnosed with cancer 
propelled them into “another world”. Alesha revealed how for her, the hospital 
environment felt like “quarantine”, exposing her to situations she could never have 
imagined: 
“Yeah you feel like you have been put in quarantine and that everyone... 
because you don’t see all of them outside...you don’t see girls with bald 
heads everywhere...so you feel like you’re in you’re own world”  
(Alesha, 331-334) 
 
Claire also commented on the unique and at times “shocking” nature of the hospital 
environment, talking about how she would often see “babies”, and “toddlers” 
“going through” treatment. This upturned reality was also difficult for Jack, who 
described how he often struggled with seeing the effects of cancer treatment: 
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 “being on the ward all of a sudden, you're seeing people walking   
by...missing arms or there was one girl who had her eye removed...it’s like 
...you don't see that sort of stuff...and to all of a sudden be put in there it's… 
it's hard to see” 
(Jack, 956-960)
  
In addition to discovering this new world, being exposed to other people with cancer 
was something that Joe found difficult. Reflecting on how seeing others go through 
treatment, was a stark reminder of what might happen to him: 
“I was seeing other people and I was thinking I'm going to be like that, 
because I've got cancer, but then after a bit I just started to think about it a 
bit more and a bit more, and each loss, it started to affect me more”  
(Joe, 1085-1088)  
 
2.3.3.3 ‘Finding a safe harbour’ 
Given the diverse and at times chaotic nature of cancer treatment, many of the 
participants spoke to the need for a place of solace and safety. For Adam, this was in 
the form of medical staff, putting his faith in the team around him, “they know what 
they're doing so just go with whatever they are saying”. This was echoed by Joe who 
took comfort from the fact he was “in the best hands” and receiving the “best 
treatment” available.  
 
 Despite certain challenges, the ward also epitomised a place of safety for some 
young people. Alesha reflected that despite it feeling like “quarantine”, staff tried to 
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make her stay as comfortable as possible which was helped by a range of facilities 
and activities which made her feel more at “home”:  
“you have TVs, X Box, you have music...there was a music teacher that 
comes and teaches you keyboard, guitars, if you want to sing you sing...it 
kind of brings you...makes you feel like home…” 
 
(Alesha, 364-368) 
 
Such mixed feelings were also felt by Jack, who despite finding the hospital 
environment challenging, sought comfort from nurses and support staff. Jack also 
commented on the new relationships he had formed with other cancer patients, 
speaking about how it was easier to relate to one another as they were “in the same 
boat”.  Such unity was something shared amongst most of the participants and is 
articulated here by Jack’s experience: 
“there was one night in particular where it was like a camp fire… we were 
all up …all the lads there was four in one bay everyone was or talking 
laughing that was, that was a great night” 
(Jack, 1236-1239) 
 
Not all young people found comfort from staff or other young people with cancer, 
instead turning to their family and friends. Claire described how she did meet other 
young people, but did not “make strong connections”, instead describing how she 
was happy with her support network and wanted to “stick to them”. For Abigail and 
Adam, the biggest sense of support came from their family, reflecting on how their 
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experiences lead to them “spending more time” with loved ones, characterised here 
by Abigail’s reflection on the relationship with her mom:  
“I think, I am a lot closer to my mom which is like a positive, because I have 
spent so much time with her in hospital, err, we definitely, like we get each 
other a lot more because we have been almost, we have had to be together 
because I don’t want to be on my own” 
(Abigail, 555-559) 
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2.4. Discussion 
 
 
2.4.1 Discussion of findings  
This study brought light to the lived experiences of a diverse range of young people 
(aged 13-24) with cancer. Three superordinate themes emerged from the data 
displaying the complex and often demanding picture of what it is like to live with 
cancer as a young person in the UK. From comprehending a life with cancer, to 
coping with the adversarial nature of treatment, participants navigate a host of trials 
and tribulations, questioning their identity and the world in which they have been 
propelled into. Demonstrating resilience and resolve young people reflected on how 
such experiences had contributed to a new sense of purpose and meaning, all of 
which was driven by a determination to survive and overcome their condition.   
 
2.4.1.1 A natural injustice 
An assortment of lived truths corroborated the varied and yet harmonious 
experiences of living with and undergoing treatment for cancer as a young person. 
This included grappling with a new-found reality and a coming to terms with a new 
characteristic which at times felt like it embodied who they were.  This research 
supported findings found amongst the adult population, with a number of young 
people participating in self-recrimination in order to make sense of their diagnosis 
(Block, Dafter, & Greenwald, 2006).   
 
Many of the young people involved within the project reflected on the strenuous and 
often incarcerating nature of cancer treatment, raising questions about how young 
people are prepared for treatment. As such, mental health input as recommended by 
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the NICE guidelines (NICE, 2014) may be able to facilitate conversations that 
encapsulate the intense nature of treatment and mediate any concerns and 
apprehensions.   
 
2.4.1.2 Get ready for battle: Cancer as an adversary to youth 
Findings here demonstrated the often belligerent and adversarial nature of treatment, 
together with the resilient and optimistic approach young people adopted in order to 
manage and retain their identity. Cancer appeared to be an antagonist to youth, and at 
times this raging and powerful force seemed intent on disrupting such a vital and 
tentative developmental stage. Living with cancer as a young person propelled this 
cohort into a world far beyond their years, with young people having to negotiate 
and manage a range of emotions and important life decisions. Furthermore, many 
participants spoke about the loss of their new-found independence as a result of 
treatment, becoming more reliant on family members for support. This retreat to 
dependency supports the findings of Grinyer (2007) and Lewis et al. (2013), who 
found young people’s development was often arrested by their cancer experience.  
 
Evident throughout the narratives of those involved was a sense of being separate to 
their cancer. Many young people spoke about how it was their body that was failing 
rather than their mind, taking a more omnipotent position in order to focus their 
attention on recovery. A positive and optimistic outlook seemed pertinent to this 
cohort, who felt focusing on negative aspects of their condition may somehow hinder 
the recuperation of their healthy self. Despite early research suggesting patients 
demonstrating a “fighting spirit” were more likely to be disease free five to ten years 
post assessment (Greer, Morris, & Pettingale, 1979), multiple methodological 
limitations including small sample sizes and lack of statistical control for node status 
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means such claims have been refuted. Furthermore, with findings from a systematic 
review conducted by Petticrew, Bell, and Hunter (2002) revealing little evidence that 
optimism or “positive psychology” effects cancer progression and survival, the 
validity of such a widespread notion has to be questioned. Research has shown that 
patients can be overwhelmed with guilt or worry when being unable to remain 
positive, and as such health professionals must be aware and allow room for more 
complex or “negative” emotions (Dafter & Greenwald, 2006; Coyne & Tennen, 
2010).   
 
Finally, many of the young people expressed a more open minded and mature 
perspective as a result of their experiences, focusing more on living life and making 
memories. This was consistent with findings from previous research who found that 
young people can often have a changed outlook on life following a diagnosis of 
cancer (Lewis et al., 2013). Moreover, findings from a recent systematic review have 
highlighted how such reappraisals of life have the capability of generating greater 
self-development and transformation potential, akin to illness related Post Traumatic 
Growth (Hefferon, Grealy, & Mutrie, 2009). However, not all appraisals were seen 
as progressive, with some members of the sample speaking to the “loss” of their 
younger years, suggesting a somewhat acrimonious response to having to deal with 
such responsibility at this youthful age.  
 
2.4.1.3 The upside down: A parallel universe  
A felt sense of being separate to the general population, together with exposure to a 
new and often frightening world can lead to young people feeling disconnected from 
the world around them.  The present study supports findings from previous research 
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by Grinyer (2007) which depicts several key areas of young people’s lives being 
affected as a result of their diagnosis. Friendship groups for some participants were 
stretched, with the young people often feeling “out of the loop”. With findings from 
children’s charity CLIC Sargent revealing 70% of young people experiencing 
depression at some point in their cancer journey, more needs to be done to help 
promote the importance of peer support and young people’s wellbeing (CLIC 
Sargent, 2017). Furthermore, recent campaigns such as Macmillan’s ‘life with cancer 
is still life’ could be expanded to include members of this population and help 
combat reflections like “I'm still me, but they can't see that” as shared by Joe.  
 
Being thrust into hospital environments exposed the young people in our sample to 
the harsh reality of cancer treatment. Many participants reflected on the sights they 
witnessed whilst in hospital, adding how unusual and at times “hard” this was. With 
this in mind it is perhaps unsurprising that studies have reported incidences of 
cancer-related Post Traumatic Stress Disorder/Symptoms (PTSD/PTSS) ranging 
from 4.7% (Kazak et al., 2004) to 21% (Butler, Rizzi, & Handwerger, 1996) in 
childhood cancer survivors (Bruce, 2006). Despite guidelines stipulating the 
importance of emotional and psychological support for cancer patients, the focus for 
many of the young people was on treatment and physical recovery. Staff and support 
services, whilst needing to prioritise young people’s physical health, should not 
neglect their emotional world. Simple meetings that help young people prepare for 
their own treatment, as well as what they may witness whilst in hospital may help 
reduce the prominent levels (90%) of anxiety reported by young people in a recent 
study (CLIC Sargent, 2017).  
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Despite these experiences, young people found solace in the hospital environment, 
together with their family and friends. Thus, suggesting that for the large part 
recommendations made in “A blueprint of care for teenagers and young adults with 
cancer” remain helpful, especially in relation to the ward environment and holistic 
care approach (Smith et al., 2012) 
 
2.4.2 Methodological limitations  
With a limited sample size, results cannot be transferred to all young people (13-24) 
with cancer. However, the convergence across the participants narratives together 
with the richness of detail provided, offers validity to these shared experiences. 
Furthermore, the potential limitations associated with one participant having finished 
treatment before the interview took place, have been considered with their narrative 
still providing a rich and authentic account of their cancer journey.    
 
Finally, the difficulties associated with accessing this vulnerable population have 
been explored. Lengthy treatment regimens and associated side effects, together with 
the separation of services depending on age may have accounted for non-
participation for some young people.  
 
2.4.3 Clinical and service implications  
The invidious position of being a young person with cancer, stresses the need for 
attuned and aligned clinical relationships. Furthermore, the environments in which 
young people are treated need to be a place of safety and acceptance, allowing for 
open discussions that speak to the emotional impact a diagnosis of cancer can have. 
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Services need to continue to support young people in a holistic manner, catering to 
the needs of individuals rather than the collective. Given the themes associated with 
self- recrimination and the need to remain “positive”, clinicians must juggle the 
delicate and multifaceted task of providing a sense of hope and promoting young 
people’s strength and determination, whilst also allowing for more difficult 
conversations. Given the potential difficulties in starting such discussions, 
psychology could support medical staff by providing training, facilitating reflective 
practice groups and offering supervision in order to help promote staff development.  
 
Despite similarities relating to their cancer experience, age of diagnosis was linked 
to different experiences. The younger members of this cohort seemed to focus more 
on peer relationships and the effects cancer has had on their development. Whilst 
relating to these experiences, older participants also spoke to challenges in personal 
and romantic relationships, and as such clinicians must steer clear of a one size fits 
all approach, making adjustments depending on individual need. Thus, assessment 
and formulation encompassing individual’s experiences along with parental 
involvement is crucial in ensuring an holistic and distinct care package.  
 
2.4.4 Recommendations for future research 
Divergence amongst the young people’s accounts was mainly associated with 
participants’ age. With such a broad range (13-24), future research should attempt to 
explore experiences amongst different ages within this cohort.  
 
Given this was the first IPA study with this population, social factors were not 
considered when recruiting participants. Future research could target a range of 
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participants who hold supplementary intersects of reduced privilege such as minority 
ethnic groups or those with comorbid or complex needs. Furthermore, gender 
specific experiences could be explored, to help provide more detailed accounts of 
experience.  
 
With findings from a recent mixed methods study revealing elevated levels of 
anxiety and depression amongst young people with cancer, a more in depth 
qualitative enquiry focused on exploring potential precipitating factors may also be 
useful (CLIC Sargent, 2017).  
 
2.5 Conclusion   
This comprehensive qualitative enquiry has contributed to the limited literature 
concerning young people’s experiences of cancer. Supporting findings from other 
qualitative studies, young people reported a diverse range of experiences which at 
times hindered their development. Navigating the world of cancer diagnoses and 
treatment is often fraught with challenges, however stories of resilience and 
determination are scattered throughout these young people’s narratives.  
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3.1. Introduction  
A fundamental part of clinical psychology training, reflexivity and reflective 
practice, has propagated professional practice in recent years. Despite such 
unprecedented growth, the delineation of reflection can differ extensively, not only 
across, but within the same professions (Finlay, 2008). Notwithstanding a lack of 
consensus (Eraut, 2004; Finlay, 2008), I look at reflection as the opportunity to 
examine the influence that I can have upon my work, both as a clinician and as a 
researcher. With several learning models (Kolb, 1984; Johns; 1995; Gibbs, 1998) 
positioning self-reflection as the antecedent to change and growth, this chapter aims 
to provide a cogitated account of the reciprocal relationship between myself and my 
research. I will incorporate experiences of the entire research process, from 
conception to completion, and explore the effects this activity has had on my life at 
present and undoubtedly will have in the future. This process of reflection has been 
guided by a research journal and reflective diary written over the course of my 
training, and where relevant I have incorporated therapeutic models to help provide 
shape and clarity to my account.  
 
3.2. Why Health? 
“Exploring people’s experiences of adversity” and “Investigating Resilience and 
Spirit”, were just two quotes noted in my first-year reflective diary when thinking 
about what I would like to research. Although these statements could be just as 
fitting for exploring people’s experiences of a variety of hardships, my own personal 
life guided me to a more health related topic. My maternal grandfather was 
diagnosed with Huntington’s Disease (HD) in 2014, and my maternal grandmother 
had just “got the all clear” from ovarian cancer when I joined the course. These 
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experiences propelled me to a world of medical appointments, clinics, and 
encounters I had previously not recognised or understood, exposing me to how 
fragile and yet durable we are as humans. It was this collocation that acted as the 
starting point for my research journey, the start of a desire to want to explore and 
then express people’s stories relating to their own health experiences. This, coupled 
with my passion and love for working with young people, inspired me to embark on 
the topics enlisted within this thesis.  
 
 
3.3. Things change   
“Grief does not change you, Hazel. It reveals you” 
John Green, The Fault in Our Stars 
 
As referenced above, when embarking on this research journey, both my maternal 
grandfather and grandmother had their own experiences of severe health problems. 
However, what seemed to be under control started to quickly unravel during my time 
on the course.   
 
In January 2017, my family and I suffered the loss of my Nan. Despite encountering 
death of loved ones prior to this, I can honestly say that this was the hardest and 
most difficult I have yet to encounter. I had many questions and very few answers, 
and given the stage of my research, I felt confused and unsure about my progress 
with this subject matter. In October of the same year, my grandfather’s symptoms of 
Huntington’s Disease started to progress, resulting in him moving into supported 
living accommodation and leaving the house he had loved since I was young. These 
experiences again made me think about my research choices, and despite not 
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knowing what the future had in store, I could not help but question why I chose these 
topics.  
 
I had previously reasoned that my choice of project resonated from a desire to better 
understand the experiences of those suffering from ill health. Furthermore, I believed 
it was important to study a topic in which I was interested and had a passion for, 
given research had never been the primary motivator for my career in psychology. 
However, on reflection in addition to the reasons listed above I feel my choice of 
topic may have fulfilled another role, one that helped me feel more connected with 
the experiences of my family. Since gaining a place on this course, I had left my 
home town which, coupled with increased academic pressures, led me to feel 
increasingly detached from my family. I know that despite doing the most I could, 
and being there for my family during these incidents, I was still left with a sense of 
guilt and sadness. This made me think about the triangle of conflict, and how 
defences are often employed to manage anxiety resulting from an underlying feeling 
(Malan, 1995). I started to think about how the guilt I held because of being more 
absent from my family, may have been sublimated into my choice of research in 
order to feel more connected (Lemma, 2003).  Sublimation represents a process by 
where we invest our energy associated with difficult feelings or impulses into a task 
or activity. As such, it may be that my guilt and sadness about feeling disconnected 
from my family was diverted into the more prosocial or proactive behaviour of 
conducting my research.   
 
Reflecting on these experiences, emphasises the importance of family and self-care. 
The literature relating to self-care amongst psychologists highlights a potential 
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deficit in this area, despite it being a crucial part of becoming an effective clinician 
(Figley, 2002; Norcross, 2002). Throughout my training, I have been heavily 
influenced by models of compassion and dynamic therapies that focus on the 
importance of emotional regulation and self-care (Coughlin & Katzman, 2013; 
Gilbert, 2010). Despite this, I often struggled to look at my own emotional world, 
and as such had difficulty in applying some of the very principles I recommend to 
my patients. Taking the time to consider these experiences has been incredibly 
useful. I noticed a direct shift in my behaviour in the weeks leading up to 
submission, offering myself gentle invitations to check in, as well as give myself 
permission to take breaks and reconnect with my loved ones. I found this process 
had a beneficial impact on my wellbeing, but also my work, both in relation to my 
project and clinical responsibilities.  
 
3.4. In, Out and In-between 
The qualitative researcher’s perspective is perhaps a paradoxical one: it is to be 
acutely tuned-in to the experiences and meaning systems of others—to indwell—and 
at the same time to be aware of how one’s own biases and preconceptions may be 
influencing what one is trying to understand.  
Maykut and Morehouse, 1994, p. 123 
 
Although free from cancer, my close relationship with the disease and its effects on 
my family, together with my new found “at risk” status in relation to HD, places me 
closer to the phenomenon under investigation. There is an array of literature 
exploring membership roles in qualitative research, with theories relating to both 
insider and outsider positions being debated over time (Dwyer & Buckle, 2009; 
Milligan, 2016).  
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An “insider” position relates to a researcher who has personal experience and 
belongs to the same cohort as their participants, while an “outsider” sits outside said 
group and has no prior union to the research population or field (Gair, 2012). 
Alongside these positions lie inherent questions and contests, often relating to 
objectivity and bias. Adler and Adler (1987) delineate “complete member 
researchers” or ‘insiders’ may struggle with role conflict and confusion, being at risk 
of responding to the participants and or their data from a perspective other than that 
of a researcher. On the other hand, having exposure to the phenomenon you are 
studying affords a unique position of understanding and identification that may be 
missed by those with no prior experience (Dwyer & Buckle, 2009).  
 
For me, the process of qualitative research itself cannot be objective. As a qualitative 
researcher, I am not separate from my research, but rather firmly positioned in the 
middle of it. One could argue regardless of personal exposure, we carry the stories of 
our participants around with us, letting them in to our world for us to make sense of 
them. In a sense, our personhood affects the research as much as the research affects 
our personhood. To try and create a “balance” by where my experiences could be 
valuable but not overbearing, I utilised “bracketing interviews” and my research 
journal to help identify and explore my own preconceptions and ensure they did not 
dominate my analysis. Bracketing can refer to a reflexive exercise whereby the 
researcher endeavours to recognise potential areas of conflict or bias within 
themselves, in order to ‘bracket’ (not ignore) them so as to reduce their influence 
upon the data (Ahern, 1999).  For me, there were multiple preconceptions about what 
it would be like to be diagnosed with cancer, born from my own experiences, and 
those I had gathered via the media. I had anticipated that in addition to devastation 
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and distress, a sense of resilience would emerge. Furthermore, I had wondered about 
how these young people would make sense of their situation, and whether it would 
involve a certain amount of self-recrimination or attribution to external forces as 
seen in the adult population (Block, Dafter, & Greenwald, 2006).  It was apparent 
when thinking about my own position, I could anticipate a certain degree of 
attribution to previously-ill-advised behaviour, whether that be linked or not. It was 
imperative that I obtained an awareness of these ideas and beliefs, so that I could be 
free to listen to the stories of my participants without imposing my own impressions 
and theories onto them. In this instance, themes of attribution and resilience were 
inherent in the data set. However, by acknowledging my own thoughts and ideas, I 
was able to help ensure this was a true reflection of the sample and not myself.  
It was by engaging in these reflexive processes that I came across a third position, 
the notion of the “space in-between” (Dwyer & Buckle, 2009).  This was a space that 
opposed the dichotomy of insider versus outsider status and instead celebrated the 
dialectical nature of qualitative research (Dwyer & Buckle, 2009). It recognises that 
in spite of whether we fall closer to the insider position or not, our perspective just 
like our participants’ is unique and shaped by our own individual experiences.  
 
3.5. Ethics and Recruitment  
Given the topic under investigation, I was acutely aware of the need for sound 
ethical and moral considerations. However, I did not anticipate the extent to which 
this process challenged my thoughts about my ability and capacity to complete this 
project.  
 
I originally started the process of obtaining ethical approval for this research in 
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January 2017, with approval from all relevant departments not being granted until 
September 2017. Over the course of those eight months, I attended multiple 
meetings, panels and service user feedback groups to try and ensure the most robust 
and ethically sound project possible. As this research involved participants within 
the NHS, it required ethical approval from my sponsoring organisation (Coventry 
University), The Health Research Authority (HRA) as well as permissions from both 
research and development departments at the local specialist cancer sites. Thinking 
about this process and in looking through my reflective journal, I remember a sense 
of feeling frustrated and trapped by both the length and restrictive nature of this 
activity. I found that it was difficult to satisfy all the parties involved, with 
conflicting information being provided at different points throughout the process. 
Furthermore, the perceived extent of worry and apprehension surrounding the project 
was surprising, and at times discouraging. I started to question my ability as a 
researcher, and in turn noticed an increase in my own anxiety about potentially 
working with this population. I utilised supervision to help explore these feelings, 
and address concerns I had about the feasibility of the project given these challenges. 
I found it was useful to reflect on the importance of ethical principles and how rather 
than interpreting feedback as a negative appraisal on my ability, to see it as a vital 
tool to help prevent negligence or harm. Furthermore, it was through this process 
that I was further able to accept that in my desire to want to tell the stories of this 
underrepresented sample, I may have overlooked certain elements required to ensure 
the project was safe not only for the young people involved, but also myself as a 
researcher. Working in this area has been emotionally demanding at times, and I do 
feel that this is something that I may have overlooked when planning this project. 
Obtaining support from both my academic and clinical supervisors during this 
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journey has been paramount to its success and my ability to keep moving forward. 
 
In addition to the challenges associated with ethics, recruitment for this study was 
also very difficult. I started the recruitment process in September 2017, and by the 
end of February 2018, had only interviewed four people, all of which were over the 
age of 18. At this point I was extremely anxious that I would not be able to recruit a 
sufficient number of young people into the study and that I would not secure 
representation for the lower half of the age range (13-24). The process of recruitment 
was heavily reliant on the staff from the two local specialist cancer services, and 
whilst all the staff were extremely helpful and supportive, I was at times curious 
about the potential parallel processes at play.  
 
Both Searles (1955) and Hora (1957)  describe parallel processes as potential 
unconscious identifications with a client and their needs. During my time with staff I 
was often curious as to whether those involved in the care of young people who fell 
within the lower end of my sample (13-16) were more apprehensive about the 
project. I noticed their involvement at times was more distant, often contacting me 
via email rather than by phone or arranging meetings. Furthermore, when speaking 
to certain members of the team their approach was in certain instances indifferent, 
especially compared to clinical staff tasked with caring for young people aged 16-24.  
Through the use of clinical supervision, and retrospectively now that the data 
collection is over, I can also resonate with this potential divergence. Looking back at 
the interview process, I did notice slight differences in my initial feelings when 
talking to the two younger members of the sample. By the end of our time together, 
any initial hesitation had subsided, but this experience did leave me wondering if 
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there was a greater pull to protect or shield the younger participants. Since speaking 
to staff and indeed using my own reflections, I do feel more work in exploring our 
own feelings and perceptions of those we care for is needed. Furthermore, although 
it is imperative that we protect any participant from harm, especially those that are 
younger, by engaging them in research we are in a sense dignifying them and their 
experiences. Despite these challenges, I have learnt more about the importance of 
perseverance and determination when recruiting and researching hard to reach or 
vulnerable populations. As such, when thinking about future research, it would be 
wise to factor in the potential delays inherent with multiple ethical applications and a 
more obscure sample, especially given the multiple demands and clinical 
responsibilities inherent within a qualified position.  
 
3.6 I was not expecting that: being a researcher, a clinician and a human 
On returning to work after the Christmas break, I opened an email from a member of 
staff at one of the local specialist cancer services, informing me that one of the 
participants in my study had sadly died. As detailed above, my beliefs and position 
as a qualitative researcher means I attempt to embody the stories of those I am 
working with, letting them penetrate my life in order to try and understand their 
meaning. I did not see the meeting with this young person as just an “interview” but 
rather an “encounter” whereby I had the opportunity to see inside their world for a 
brief time.  
 
I was left with a profound sense of sadness at this news, especially given the fragile 
and, at times, despairing narrative of the young person in question. I also had many 
questions, particularly in relation to their data and potential inclusion in the project. 
To help ensure I followed procedure I sought guidance from the HRA, which 
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stipulated that given the young person in question contested to the project prior to 
their death and was capacitous at the time, their account could be used. Furthermore, 
reflecting on our conversations prior to the interview, the young person talked about 
their desire to take part in this project, expressing how they wanted to contribute to 
something that could help other young people or the services that help them. With 
this in mind, I felt more comfortable in using their account, however was concerned 
about ensuring I do justice to their and the other young people’s stories. Reflecting 
on the presence of these feelings enabled me to channel them into my work, helping 
ensure I spoke to the authentic and rich narratives I had been privileged to hear.  
 
Utilising supervision to help recognise certain pulls, has helped me realise the need 
for a balance between subjectivity and objectivity as a researcher. As a human and 
clinician, I wanted to continue my involvement and contact the young person’s 
family to express my condolences. However, it was by recognising that my 
objectivity as a researcher may have been a reason why they were able to speak to 
such length about their experience that assisted me to take a more cogitated 
approach.  By identifying the friction that lay between my role as a researcher and 
clinician, I was able to reflect on the potential harm I may do by speaking to his 
family, especially as I did not have ethical approval or their consent to do so.   
 
3.7 Conclusion  
The research detailed within this thesis not only represents an academic requirement, 
but a personal voyage of both myself and the young people involved. I first started to 
contemplate research ideas in my first year of training, almost two years ago. 
Looking back, the change and growth in myself as a clinician and researcher is 
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undeniable. I have spoken about how this research was born and how over time it has 
impacted me on both a personal and professional level. This project has shown me 
the importance of perseverance, especially in relation to recruitment and ethics, but 
has also highlighted how I position myself in relation to research and the importance 
of a balanced approach.  
 
Exploring the link between researcher and research together with “In” and “Out” 
positions has lead me to believe the two are not separate entities but instead exist in 
parallel. Writing this thesis and reflecting on my experiences of this course more 
generally, has substantiated the importance of reflection on good and ethical 
practice, and is something that I will take forward in my life.  
 
Further to this, embarking on this process has lead me to think more about my own 
personal identity especially in relation to my sample. My sense of privilege as a 
“healthy” young white male, has afforded me multiple opportunities in life, and 
rather than feeling guilty about these, I need to utilise them in order to help others 
who may be in a less fortunate position.  
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General guidelines for preparation and submission  
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Manuscripts should be checked for content and style (American English spelling, 
punctuation, and grammar; accuracy and consistency in the citation of figures, tables, 
and references; stylistic uniformity of entries in the References section; etc.) 
Comments section: Authors should detail in the comments section of the submission 
that the manuscript is submitted solely to this journal and was not published 
elsewhere, and disclose details of any previous or anticipated publication history 
related to the manuscript's content. Submission is a representation that the 
manuscript has not been published previously and is not currently under 
consideration for publication elsewhere. 
Manuscript Preparation 
1. Type double-spaced and include all illustrations and tables. Original research 
articles should be no longer than 25 double-spaced typed pages and qualitative 
research no longer than 40 double-spaced typed pages. 
2. Title page: A title page is to be provided and should include the title of the article, 
authors name (no degrees), authors affiliation, and suggested running head. The 
affiliation should comprise the department, institution (usually university or 
company), city, and state (or nation) and should be typed as a numbered footnote to 
the author’s name. The suggested running head should be less than 80 characters 
(including spaces) and should comprise the article title or an abbreviated version 
thereof. The title page should also include the complete mailing address, telephone 
number, fax number, and e-mail address of the one author designated to review 
proofs. 
3. Abstract: An unstructured abstract is to be provided, approximately 200 words 
4. Key words: A list of 3-10 key words is to be provided directly below the abstract. 
Key words should express the precise content of the manuscript, as they are used for 
indexing purposes. 
5. Section headings: All major sections should carry section headings (such as 
Introduction, Methods, Results, Discussion, Conclusions, etc.) type centered. Side 
headings in Methods section should include, as appropriate: Participants, 
Instrumentation, Procedures, and Data Analysis. Side headings in Discussion should 
include: Study Limitations, Practice Implications, and Research Recommendations. 
All Acknowledgements (including those for grant and financial support) should be 
typed in one paragraph (so-headed) on a separate page that directly precedes the 
References section. 
6. Reference list: The journal follows the reference and citation style 
recommendations of the Publication Manual of the American Psychological 
Association (APA style). See also: http://apastyle.apa.org/ 
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this order): last name and initials of authors, year published, title of article, name of 
publication, volume number, and inclusive pages. Where there are seven or more 
authors, abbreviate the seventh and subsequent authors as et al. 
Refer to the references in the text by name and year in parentheses. Multiple 
citations should be listed alphabetically by author’s last name.  
7. Illustrations: Illustrations (photographs, drawings, diagrams, and charts) are to be 
numbered in one consecutive series of Arabic numerals. The captions for 
illustrations should be provided. Photographs and drawings should show high 
contrast. Electronic should be in TIFF or EPS format (1200 dpi for line and 300 dpi 
for half-tones and gray-scale art). Color art should be in the CMYK color space. A 
hard copy of photographs or illustrations may be requested prior to publication. 
8. Tables: Tables should be numbered (with Roman numerals) and referred to by 
number in the text. Each table should be on a separate sheet of paper at the end of the 
submission. Center the title above the table, and type explanatory footnotes 
(indicated by superscript lowercase letters) below the table. 
9. Footnotes: Footnotes should be avoided. When their use is absolutely necessary, 
footnotes should be numbered consecutively using Arabic numerals and should be 
typed at the bottom of the page to which they refer. Place a line above the footnote, 
so it is set off from the text. Use the appropriate superscript numeral for citation in 
the text. 
10. Pedigrees: Pedigrees should follow the recommendations for standardized 
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Bennett, R. L. , Steinhaus, K. A., Uhrich, S. B., O’ Sullivan, C. K., Resta, R. G. , 
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Counseling, 17, 424-433. 
11. Conflict of Interest: Conflict of interest statements should be present on every 
manuscript before the References section. The statement 
should mention each author separately by name. Recommended wording is as 
follows: 
Author X declares that he has no conflict of interest. 
Author Y has received research grants from Drug Company A. 
Author Z has received a speaker honorarium from Drug Company B and owns stock 
in Drug Company C. 
If multiple authors declare no conflict, this can be done in one sentence: 
Author X, Author Y and Author Z declare that they have no conflict of interest. 
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12. Human Studies and Informed Consent: For studies with human subjects, please 
include the following statement before the References section: 
'All procedures followed were in accordance with the ethical standards of the 
responsible committee on human experimentation (institutional and national) and 
with the Helsinki Declaration of 1975, as revised in 2000 (5). Informed consent was 
obtained from all patients for being included in the study.' 
If any identifying information about patients is included in the article, the following 
sentence should also be included: 
'Additional informed consent was obtained from all patients for which identifying 
information is included in this article.' 
13. Animal Studies: For studies with animals, include the following sentence in the 
manuscript before the References section: 
'All institutional and national guidelines for the care and use of laboratory animals 
were followed.' 
If the authors did not carry out animal studies as part of their article they must 
include the following statement in the manuscript before the References section: 
'No animal studies were carried out by the authors for this article' 
The editors reserve the right to reject manuscripts that do not comply with the above-
mentioned requirements. The author will be held responsible for false statements or 
failure to fulfil the above-mentioned requirements. 
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Applicant:  
Joshua Spooner  
  
Project Title:  
Experiences of predictive genetic testing for Huntington’s disease: A meta-
synthesis of the qualitative research  
  
This is to certify that the above named applicant has completed the 
Coventry University Ethical Approval process and their project has 
been confirmed and approved as Low Risk  
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        24 August 2017  
  
Project Reference Number:  
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Adapted CASP instrument 
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Appendix D 
Inter-rater reliability coefficient (Kappa) scores 
 
Overall Kappa score: 
 
Kappa score for Andersson et al, 2013 paper:  
Symmetric Measures 
 Value 
Asymptotic 
Standard Errora Approximate Tb 
Approximate 
Significance 
Measure of Agreement Kappa .657 .227 2.829 .005 
N of Valid Cases 12    
 
Kappa score for Cox & McKellin, 1999 paper: 
Symmetric Measures 
 Value 
Asymptotic 
Standard Errora Approximate Tb 
Approximate 
Significance 
Measure of Agreement Kappa .867 .128 4.083 .000 
N of Valid Cases 12    
  
Kappa score for Gong et al, 2016 paper: 
Symmetric Measures 
Symmetric Measures 
 Value 
Asymptotic 
Standard Errora Approximate Tb 
Approximate 
Significance 
Measure of Agreement Kappa .856 .057 9.859 .000 
N of Valid Cases 72    
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 Value 
Asymptotic 
Standard Errora Approximate Tb 
Approximate 
Significance 
Measure of Agreement Kappa .657 .227 2.829 .005 
N of Valid Cases 12    
 
Kappa score for Sobel & Cowan, 2003 paper: 
Symmetric Measures 
 Value 
Asymptotic 
Standard Errora Approximate Tb 
Approximate 
Significance 
Measure of Agreement Kappa .860 .134 4.072 .000 
N of Valid Cases 12    
 
Kappa score for Taylor, 2004 paper: 
Symmetric Measures 
 Value 
Asymptotic 
Standard Errora Approximate Tb 
Approximate 
Significance 
Measure of Agreement Kappa .867 .128 4.083 .000 
N of Valid Cases 12    
 
Kappa score for Theed et al, 2017 paper: 
Symmetric Measures 
 Value 
Asymptotic 
Standard Errora Approximate Tb 
Approximate 
Significance 
Measure of Agreement Kappa 1.000 .000 4.846 .000 
N of Valid Cases 12    
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Appendix E 
Meta-ethnographic method 
The seven steps identified by Noblit and Hare (1988) as summarised by France et al. 
(201 pp 5) 
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Appendix F 
Author guidelines for submission to the British journal of Health Psychology 
 
Author Guidelines 
The aim of the British Journal of Health Psychology is to provide a forum for high 
quality research relating to health and illness. The scope of the journal includes all 
areas of health psychology as outlined in the Journal Overview. 
The types of paper invited are: 
• papers reporting original empirical investigations, using either quantitative or 
qualitative methods, including reports of interventions in clinical and non-clinical 
populations; 
• theoretical papers which report analyses on established theories in health 
psychology; 
• we particularly welcome review papers, which should aim to provide systematic 
overviews, evaluations and interpretations of research in a given field of health 
psychology (narrative reviews will only be considered for editorials or important 
theoretical discourses); and 
• methodological papers dealing with methodological issues of particular relevance 
to health psychology. 
 
Authors who are interested in submitting papers that do not fit into these categories 
are advised to contact the editors who would be very happy to discuss the potential 
submission. 
 
All papers published in The British Journal of Health Psychology are eligible for 
Panel A: Psychology, Psychiatry and Neuroscience in the Research Excellence 
Framework (REF). 
1. Circulation 
The circulation of the Journal is worldwide. Papers are invited and encouraged from 
authors throughout the world. 
2. Length 
Papers describing quantitative research (including reviews with quantitative 
analyses) should be no more than 5000 words (excluding the abstract, reference list, 
tables and figures). Papers describing qualitative research (including reviews with 
qualitative analyses) should be no more than 6000 words (including quotes, whether 
in the text or in tables, but excluding the abstract, tables, figures and references). The 
Editors retain discretion to publish papers beyond this length in cases where the clear 
and concise expression of the scientific content requires greater length. 
3. Editorial policy 
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The Journal receives a large volume of papers to review each year, and in order to 
make the process as efficient as possible for authors and editors alike, all papers are 
initially examined by the Editors to ascertain whether the article is suitable for full 
peer review. In order to qualify for full review, papers must meet the following 
criteria: 
• the content of the paper falls within the scope of the Journal 
• the methods and/or sample size are appropriate for the questions being addressed  
• research with student populations is appropriately justified 
• the word count is within the stated limit for the Journal (i.e. 5000 words, or 6,000 
words for qualitative papers) 
4. Submission and reviewing 
All manuscripts must be submitted via Editorial Manager. The Journal operates a 
policy of anonymous (double blind) peer review. We also operate a triage process in 
which submissions that are out of scope or otherwise inappropriate will be rejected 
by the editors without external peer review to avoid unnecessary delays. Before 
submitting, please read the terms and conditions of submission and the declaration of 
competing interests. You may also like to use the Submission Checklist to help your 
prepare your paper. 
5. Manuscript requirements 
• Contributions must be typed in double spacing with wide margins. All sheets must 
be numbered. 
• Manuscripts should be preceded by a title page which includes a full list of authors 
and their affiliations, as well as the corresponding author's contact details. You may 
like to use this template. When entering the author names into Editorial Manager, the 
corresponding author will be asked to provide a CRediT contributor role to classify 
the role that each author played in creating the manuscript. Please see the Project 
CRediT website for a list of roles. 
• For articles containing original scientific research, a structured abstract of up to 250 
words should be included with the headings: Objectives, Design, Methods, Results, 
Conclusions. Review articles should use these headings: Purpose, Methods, Results, 
Conclusions. As the abstract is often the most widely visible part of your paper, it is 
important that it conveys succinctly all the most important features of your study. 
You can save words by writing short, direct sentences. Helpful hints about writing 
the conclusions to abstracts can be found here. 
• Statement of Contribution: All authors are required to provide a clear summary of 
‘what is already known on this subject?’ and ‘what does this study add?’. Authors 
should identify existing research knowledge relating to the specific research question 
and give a summary of the new knowledge added by your study. Under each of these 
headings, please provide 2-3 (maximum) clear outcome statements (not process 
statements of what the paper does); the statements for 'what does this study add?' 
should be presented as bullet points of no more than 100 characters each. The 
Statement of Contribution should be a separate file. 
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• Conflict of interest statement: We are now including a brief conflict of interest 
statement at the end of each accepted manuscript. You will be asked to provide 
information to generate this statement during the submission process. 
• The main document must be anonymous. Please do not mention the authors’ names 
or affiliations (including in the Method section) and always refer to any previous 
work in the third person. 
• Tables should be typed in double spacing, each on a separate page with a self-
explanatory title. Tables should be comprehensible without reference to the text. 
They should be placed at the end of the manuscript but they must be mentioned in 
the text. 
• Figures can be included at the end of the document or attached as separate files, 
carefully labelled in initial capital/lower case lettering with symbols in a form 
consistent with text use. Unnecessary background patterns, lines and shading should 
be avoided. Captions should be listed on a separate sheet. The resolution of digital 
images must be at least 300 dpi. All figures must be mentioned in the text. 
• For reference citations, please use APA style. Particular care should be taken to 
ensure that references are accurate and complete. Give all journal titles in full and 
provide doi numbers where possible for journal articles. For example: 
 
Author, A., Author, B., & Author, C. (1995). Title of book. City, Country: Publisher. 
Author, A. (2013). Title of journal article. Name of journal, 1, 1-16. doi: 
10.1111/bjep.12031 
• SI units must be used for all measurements, rounded off to practical values if 
appropriate, with the imperial equivalent in parentheses. 
• In normal circumstances, effect size should be incorporated. 
• Authors are requested to avoid the use of sexist language. 
• Authors are responsible for acquiring written permission to publish lengthy 
quotations, illustrations, etc. for which they do not own copyright. For guidelines on 
editorial style, please consult the APA Publication Manualpublished by the 
American Psychological Association. 
• Manuscripts describing clinical trials are encouraged to submit in accordance with 
the CONSORT statement on reporting randomised controlled trials. 
• Manuscripts reporting systematic reviews and meta-analyses are encouraged to 
submit in accordance with the PRISMA statement. 
• Manuscripts reporting interventions are encouraged to describe them in accordance 
with the TIDieR checklist. 
If you need more information about submitting your manuscript for publication, 
please email Hannah Wakley, Managing Editor (bjhp@wiley.com) or phone +44 (0) 
116 252 9504. 
6. Supporting information 
 
126 
 
We strongly encourage submission of protocol papers or trial registration documents, 
where these are in the public domain, to allow reviewers to assess deviations from 
these protocols. This will result in reviewers being unblinded to author identity. 
Supporting Information can be a useful way for an author to include important but 
ancillary information with the online version of an article. Examples of Supporting 
Information include appendices, additional tables, data sets, figures, movie files, 
audio clips, and other related nonessential multimedia files. Supporting Information 
should be cited within the article text, and a descriptive legend should be included. 
Please indicate clearly on submission which material is for online only publication. It 
is published as supplied by the author, and a proof is not made available prior to 
publication; for these reasons, authors should provide any Supporting Information in 
the desired final format. 
For further information on recommended file types and requirements for submission, 
please visit the Supporting Information page on Author Services. 
7. OnlineOpen 
OnlineOpen is available to authors of primary research articles who wish to make 
their article available to non-subscribers on publication, or whose funding agency 
requires grantees to archive the final version of their article. With OnlineOpen, the 
author, the author's funding agency, or the author's institution pays a fee to ensure 
that the article is made available to non-subscribers upon publication via Wiley 
Online Library, as well as deposited in the funding agency's preferred archive. A full 
list of terms and conditions is available on Wiley Online Library. 
Any authors wishing to send their paper OnlineOpen will be required to complete 
the payment form. 
Prior to acceptance there is no requirement to inform an Editorial Office that you 
intend to publish your paper OnlineOpen if you do not wish to. All OnlineOpen 
articles are treated in the same way as any other article. They go through the 
journal's standard peer-review process and will be accepted or rejected based on their 
own merit. 
8. Author Services 
Author Services enables authors to track their article – once it has been accepted – 
through the production process to publication online and in print. Authors can check 
the status of their articles online and choose to receive automated e-mails at key 
stages of production. The author will receive an e-mail with a unique link that 
enables them to register and have their article automatically added to the 
system. You can then access Kudosthrough Author Services, which will help you to 
increase the impact of your research. Visit Author Services for more details on 
online production tracking and for a wealth of resources including FAQs and tips on 
article preparation, submission and more. 
9. Copyright and licences 
If your paper is accepted, the author identified as the formal corresponding author for 
the paper will receive an email prompting them to login into Author Services, where 
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via the Wiley Author Licensing Service (WALS) they will be able to complete the 
licence agreement on behalf of all authors on the paper. 
For authors signing the copyright transfer agreement 
If the OnlineOpen option is not selected the corresponding author will be presented 
with the copyright transfer agreement (CTA) to sign. The terms and conditions of the 
CTA can be previewed in the samples associated with the Copyright FAQs . 
For authors choosing OnlineOpen 
If the OnlineOpen option is selected the corresponding author will have a choice of 
the following Creative Commons Licence Open Access Agreements (OAA): 
 
- Creative Commons Attribution Non-Commercial Licence (CC-BY-NC) 
- Creative Commons Attribution Non-Commercial -NoDerivs Licence (CC-BY-NC-
ND) 
To preview the terms and conditions of these open access agreements please visit 
the Copyright FAQs and you may also like to visit the Wiley Open Access 
Copyright and Licence page. 
If you select the OnlineOpen option and your research is funded by The Wellcome 
Trust and members of the Research Councils UK (RCUK) or the Austrian Science 
Fund (FWF) you will be given the opportunity to publish your article under a CC-
BY licence supporting you in complying with your Funder requirements. For more 
information on this policy and the Journal’s compliant self-archiving policy please 
visit our Funder Policy page. 
10. Colour illustrations 
Colour illustrations can be accepted for publication online. These would be 
reproduced in greyscale in the print version. If authors would like these figures to be 
reproduced in colour in print at their expense they should request this by completing 
a Colour Work Agreement form upon acceptance of the paper. 
11. Pre-submission English-language editing 
Authors for whom English is a second language may choose to have their manuscript 
professionally edited before submission to improve the English. A list of 
independent suppliers of editing services can be found in Author Services. All 
services are paid for and arranged by the author, and use of one of these services 
does not guarantee acceptance or preference for publication. 
12. The Later Stages 
The corresponding author will receive an email alert containing a link to a web site. 
The proof can be downloaded as a PDF (portable document format) file from this 
site. Acrobat Reader will be required in order to read this file. This software can be 
downloaded (free of charge) from Adobe's web site. This will enable the file to be 
opened, read on screen and annotated direct in the PDF. Corrections can also be 
supplied by hard copy if preferred. Further instructions will be sent with the proof. 
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Excessive changes made by the author in the proofs, excluding typesetting errors, 
will be charged separately. 
13. Early View 
British Journal of Health Psychology is covered by the Early View service on Wiley 
Online Library. Early View articles are complete full-text articles published online in 
advance of their publication in a printed issue. Articles are therefore available as 
soon as they are ready, rather than having to wait for the next scheduled print issue. 
Early View articles are complete and final. They have been fully reviewed, revised 
and edited for publication, and the authors’ final corrections have been incorporated. 
Because they are in final form, no changes can be made after online publication. The 
nature of Early View articles means that they do not yet have volume, issue or page 
numbers, so they cannot be cited in the traditional way. They are cited using their 
Digital Object Identifier (DOI) with no volume and issue or pagination information. 
Eg Jones, A.B. (2010). Human rights Issues. Journal of Human Rights. Advance 
online publication. doi:10.1111/j.1467-9299.2010.00300.x 
Further information about the process of peer review and production can be found in 
this document. What happens to my paper? Appeals are handled according to 
the procedure recommended by COPE. 
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Appendix G 
HRA guidance for the principles of consent for deceased participants 
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Appendix H 
Coventry University ethics approval for Chapter Two Empirical Paper 
 
 
 
 
  
Certificate of Ethical Approval  
 
Applicant:  
Joshua Spooner  
  
Project Title:  
Young peoples lived experiences of cancer: An Interpretative 
Phenomenological Analysis  
  
This is to certify that the above named applicant has completed the 
Coventry University Ethical Approval process and their project has been 
confirmed and approved as High Risk  
  
  
  
Date of approval:  
        11 May 2017  
  
Project Reference Number:  
P50456  
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Appendix I 
 
National Health Service Ethics Committee approval letter ((REC reference; 
17/WM/0235) 
 
  
  
Mr Joshua  Spooner    
Coventry University, Priory Street  Email: hra.approval@nhs.net  
Coventry  
CV1 5FB  
  
03 August 2017  
  
Dear Mr Spooner     
  
Letter of HRA Approval  
  
Study title:  Young people's lived experiences of cancer: An 
Interpretative Phenomenological Analysis  
IRAS project ID:  222228   
REC reference:  17/WM/0235    
Sponsor  Coventry University   
  
I am pleased to confirm that HRA Approval has been given for the above referenced 
study, on the basis described in the application form, protocol, supporting documentation 
and any clarifications noted in this letter.   
  
Participation of NHS Organisations in England   
The sponsor should now provide a copy of this letter to all participating NHS organisations 
in England.   
  
Appendix B provides important information for sponsors and participating NHS 
organisations in England for arranging and confirming capacity and capability. Please 
read Appendix B carefully, in particular the following sections:  
• Participating NHS organisations in England – this clarifies the types of 
participating organisations in the study and whether or not all organisations will be 
undertaking the same activities  
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• Confirmation of capacity and capability - this confirms whether or not each type 
of participating NHS organisation in England is expected to give formal 
confirmation of capacity and capability. Where formal confirmation is not 
expected, the section also provides details on the time limit given to participating 
organisations to opt out of the study, or request additional time, before their 
participation is assumed.  
• Allocation of responsibilities and rights are agreed and documented (4.1 of 
HRA assessment criteria) - this provides detail on the form of agreement to be 
used in the study to confirm capacity and capability, where applicable.  
Further information on funding, HR processes, and compliance with HRA criteria and 
standards is also provided.  
  
It is critical that you involve both the research management function (e.g. R&D office) 
supporting each organisation and the local research team (where there is one) in setting up 
your study. Contact details  
Page 1 of 8  
and further information about working with the research management function for each 
organisation can be accessed from www.hra.nhs.uk/hra-approval.   
  
Appendices  
The HRA Approval letter contains the following appendices:  
• A – List of documents reviewed during HRA assessment  
• B – Summary of HRA assessment  
  
After HRA Approval  
The document “After Ethical Review – guidance for sponsors and investigators”, 
issued with your REC favourable opinion, gives detailed guidance on reporting expectations 
for studies, including:   
• Registration of research  
• Notifying amendments  
• Notifying the end of the study  
The HRA website also provides guidance on these topics, and is updated in the light of 
changes in reporting expectations or procedures.  
  
In addition to the guidance in the above, please note the following:  
• HRA Approval applies for the duration of your REC favourable opinion, unless 
otherwise notified in writing by the HRA.  
• Substantial amendments should be submitted directly to the Research Ethics 
Committee, as detailed in the After Ethical Review document. Non-substantial 
amendments should be submitted for review by the HRA using the form provided 
on the HRA website, and emailed to hra.amendments@nhs.net.   
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• The HRA will categorise amendments (substantial and non-substantial) and issue 
confirmation of continued HRA Approval. Further details can be found on the HRA 
website.  
  
Scope   
HRA Approval provides an approval for research involving patients or staff in NHS 
organisations in England.   
  
If your study involves NHS organisations in other countries in the UK, please contact the 
relevant national coordinating functions for support and advice. Further information can be 
found at http://www.hra.nhs.uk/resources/applying-for-reviews/nhs-hsc-rd-review/.  
   
If there are participating non-NHS organisations, local agreement should be obtained in 
accordance with the procedures of the local participating non-NHS organisation.  
  
User Feedback  
The Health Research Authority is continually striving to provide a high quality service to all 
applicants and sponsors. You are invited to give your view of the service you have received 
and the application procedure. If you wish to make your views known please use the 
feedback form available on the HRA website: http://www.hra.nhs.uk/about-the-
hra/governance/quality-assurance/.  
  
HRA Training  
We are pleased to welcome researchers and research management staff at our training 
days – see details at http://www.hra.nhs.uk/hra-training/   
  
Your IRAS project ID is 222228. Please quote this on all correspondence.  
  
Yours sincerely  
  
Beverley Mashegede  
Assessor  
  
Email: hra.approval@nhs.net   
  
Copy to:  Prof Ian Marshall, Sponsor Contact    
    Dr Chris Counsell, Lead NHS R&D Contact  
  
134 
 
  
List of Documents  
  
The final document set assessed and approved by HRA Approval is listed below.    
  
 Document    Version    Date    
Copies of advertisement materials for research participants 
[Poster]  
3   05 May 2017   
Covering letter on headed paper [Cover Letter for REC]     20 July 2017   
Covering letter on headed paper [Cover Letter for REC]   01/08/2017   01 August 2017   
Evidence of Sponsor insurance or indemnity (non NHS 
Sponsors only)   
  11 May 2017   
GP/consultant information sheets or letters [GP Notification 
Letter]   
2   01 August 2017   
Interview schedules or topic guides for participants [Interview 
Guide] 
 2   16 March 2017   
IRAS Application Form [IRAS_Form_30052017]      30 May 2017   
IRAS Application Form XML file [IRAS_Form_30052017]      30 May 2017   
IRAS Checklist XML [Checklist_01082017]      01 August 2017   
Letter from sponsor     11 May 2017   
Non-validated questionnaire [Short Questionnaire ]   1   18 July 2017   
Other [Debrief Participant]   5   01 August 2017   
Other [Liability Insurance from Sponsor]     11 May 2017   
Other [Sponsor Ethics Approval Certificate]      11 May 2017   
Other [Debrief Participant]   3   05 April 2017   
Other [Debrief Parent/Guardian]   3   05 April 2017   
Participant consent form [Informed Consent Parent/Legal 
Guardian]  
5   01 August 2017   
Participant consent form [Assent 16 and under]   5   01 August 2017   
Participant consent form [Informed Consent 16 and Over]   5   01 August 2017   
Participant information sheet (PIS) [Participant Information 16 
and over ]   
5   01 August 2017   
Participant information sheet (PIS) [Participant Information 16 
and under]   
5   01 August 2017   
Participant information sheet (PIS) [Participant Information 
Parent/Guardian]   
5   01 August 2017   
Research protocol or project proposal [Research Proposal ]   5   20 July 2017   
Summary CV for Chief Investigator (CI)     23 May 2017   
Summary CV for student     23 May 2017   
Summary CV for supervisor (student research)     24 May 2017   
Summary CV for supervisor (student research)     14 February 2012   
Summary CV for supervisor (student research)        
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 Summary of HRA Assessment  
  
This appendix provides assurance to you, the sponsor and the NHS in England that the 
study, as reviewed for HRA Approval, is compliant with relevant standards. It also provides 
information and clarification, where appropriate, to participating NHS organisations in 
England to assist in assessing and arranging capacity and capability.  
For information on how the sponsor should be working with participating NHS 
organisations in  
England, please refer to the, participating NHS organisations, capacity and 
capability and Allocation of responsibilities and rights are agreed and 
documented (4.1 of HRA assessment criteria) sections in this appendix.   
The following person is the sponsor contact for the purpose of addressing participating 
organisation questions relating to the study:  
  
Name: Prof Ian Marshall  
Tel: 02476795294  
Email: i.marshall@coventry.ac.uk   
  
HRA assessment criteria   
 
Section  HRA Assessment 
Criteria  
Compliant 
with 
Standards  
Comments  
1.1  IRAS application completed 
correctly  
Yes  No comments   
        
2.1  Participant 
information/consent 
documents and consent 
process  
Yes  No comments  
        
3.1  Protocol assessment  Yes  No comments  
        
4.1  Allocation of 
responsibilities and rights 
are agreed and 
documented   
Yes  The Sponsor intends to use the 
Statement of Activities as the form 
of agreement with participating 
organisations.  
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4.2  Insurance/indemnity 
arrangements assessed  
Yes  Where applicable, independent 
contractors (e.g. General 
Practitioners) should ensure that 
the professional indemnity 
provided by their medical defence 
organisation covers the activities 
expected of them for this  
Section  HRA Assessment 
Criteria  
Compliant 
with 
Standards  
Comments  
   research study.  
4.3  Financial arrangements 
assessed   
Yes  No application for external funding 
made. No funds will be provided to 
the participating organisations.  
        
5.1  Compliance with the 
Data Protection Act 
and data security 
issues assessed  
Yes  No comments  
5.2  CTIMPS – Arrangements 
for compliance with the 
Clinical Trials 
Regulations assessed  
Not 
Applicable  
No comments  
5.3  Compliance with any 
applicable laws or 
regulations  
Yes  No comments  
        
6.1  NHS Research Ethics  
Committee favourable 
opinion received for 
applicable studies  
Yes  
  
Provisional Opinion issued 29 
June 2017. Favourable Opinion 
with conditions met issued 03 
August 2017.  
6.2  CTIMPS – Clinical Trials 
Authorisation (CTA) letter 
received  
Not 
Applicable  
No comments  
6.3  Devices – MHRA notice of 
no objection received  
Not 
Applicable  
No comments  
6.4  Other regulatory approvals 
and authorisations 
received  
Not 
Applicable  
No comments  
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Participating NHS Organisations in England  
This provides detail on the types of participating NHS organisations in the study and a 
statement as to whether the activities at all organisations are the same or different.   
This is a student study (Doctoral Thesis in Clinical Psychology) and there is one site type.  
  
The Chief Investigator or sponsor should share relevant study documents with participating 
NHS organisations in England in order to put arrangements in place to deliver the study. 
The documents should be sent to both the local study team, where applicable, and the 
office providing the research management function at the participating organisation. For 
NIHR CRN Portfolio studies, the Local LCRN contact should also be copied into this 
correspondence.  For further guidance on working with participating NHS organisations 
please see the HRA website.  
  
If chief investigators, sponsors or principal investigators are asked to complete site level 
forms for participating NHS organisations in England which are not provided in IRAS or on 
the HRA website, the chief investigator, sponsor or principal investigator should notify the 
HRA immediately at hra.approval@nhs.net. The HRA will work with these organisations to 
achieve a consistent approach to information provision.   
  
Confirmation of Capacity and Capability   
This describes whether formal confirmation of capacity and capability is expected from 
participating NHS organisations in England.  
Participating NHS organisations in England will be expected to formally confirm their 
capacity and capability to host this research.   
• Following issue of this letter, participating NHS organisations in England may now 
confirm to the sponsor their capacity and capability to host this research, when 
ready to do so. How capacity and capacity will be confirmed is detailed in the 
Allocation of responsibilities and rights are agreed and documented (4.1 of 
HRA assessment criteria) section of this appendix.   
• The Assessing, Arranging, and Confirming document on the HRA website provides 
further information for the sponsor and NHS organisations on assessing, arranging 
and confirming capacity and capability.  
  
  
Principal Investigator Suitability  
This confirms whether the sponsor position on whether a PI, LC or neither should be in 
place is correct for each type of participating NHS organisation in England and the 
minimum expectations for education, training and experience that PIs should meet 
(where applicable).  
A Local Collaborator is expected at each participating organisation.  
  
GCP training is not a generic training expectation, in line with the HRA statement on 
training expectations.  
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HR Good Practice Resource Pack Expectations  
This confirms the HR Good Practice Resource Pack expectations for the study and the 
pre-engagement checks that should and should not be undertaken  
For research team members undertaking activities that do not impact on the quality of care 
of the participant (listed in A18), a Letter of Access based on standard DBS checks and 
occupational health clearance would be appropriate.  
  
Other Information to Aid Study Set-up   
This details any other information that may be helpful to sponsors and participating NHS 
organisations in England to aid study set-up.  
The applicant has indicated that they do not intend to apply for inclusion on the NIHR CRN 
Portfolio.  
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Appendix J 
Semi-structed interview schedule 
Interview guide   
1. Can we start by you telling me a little bit about yourself?  
2. What was life like just before your diagnosis?  
3. What was life like just after you received your diagnosis?  
4. How has life been similar and different since receiving your diagnosis and undergoing 
treatment?  
5. How have your relationships with others been since your diagnosis?  
6. What is the difference between you before diagnosis to you now?   
7. How similar and or different are your thoughts about the future?   
8. Is there anything else you feel is important to tell me?  
  
Prompts:  
Can you give me an example?  
Can you expand on that a little?  
How did you feel about that?  
What did that feel like?  
What thoughts were going through your head?  
What affect did that have on you?   
You mentioned…..can you tell me what that experience means to you?  
How did you feel when that happened?  
How did that impact on you?  
  
        Interview Guide v2. 16/03/2017  
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Appendix K 
Participant information sheet 16 and over 
 
     Participant Information Sheet for  Participants 
16 and over 
 
Young peoples’ lived experiences of cancer: 
An Interpretative Phenomenological Analysis 
 
You are being invited to take part in an interview exploring your experiences 
of being diagnosed with cancer. This will form part of a research project 
being completed as part of the researcher’s doctoral thesis which is required 
for the completion of the Clinical Psychology Doctorate program at the 
Universities of Coventry and Warwick. The lead researcher is Joshua 
Spooner, a Trainee Clinical Psychologist  
 Before you decide whether you would be interested in taking part, please 
read the following information about the project and what would be involved.  
  
What is the purpose of this research?  
 Research looking at young peoples’ lived experiences of cancer is limited. 
Other projects have largely focused on the physical and social needs of 
young people. This research however wants to focus on what life has been 
like for you during this difficult time.  
  
Why have I been invited to take part in the research?  
 You have been invited to take part in this research because:  
- You are aged between 13-24 years’ old  
- You are 6 -18 months post initial diagnosis    
- You are currently undergoing treatment/are in partial remission   
  
Do I have to take part?   
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No. Participation within this study is voluntary; meaning it is entirely up to you 
whether you take part or not.  If you decide not to take part, this will have no 
impact on your treatment.   
If you do wish to take part, you will be asked to sign a consent form 
confirming you have read and understood the information sheet and wish to 
proceed. You can decide to withdraw your data up to two weeks following the 
interview without giving any reason and again without any consequence. 
This is due to the likelihood of data being analysed after this time. To 
withdraw you just need to contact Josh using the contact details at the end of 
this sheet.   
  
What will happen to me if I take part?  
 Taking part will involve the completion of a short questionnaire asking a little 
bit about you (your age, type of cancer etc.) and you will have the opportunity 
to discuss the research with Josh before deciding if you would like to sign the 
consent form and take part.   
  
If you do want to go ahead, Josh will write to your GP informing them of your 
participation. He will then contact you to set up a time where you can talk 
about your experiences of being diagnosed with cancer. The discussion can 
be held anywhere that is most convenient for you so this could be at home or 
in a meeting room at your local treatment center (Birmingham Children’s 
Hospital or the Queen Elizabeth Hospital) or at Coventry University.  
  
The conversation will largely focus on your experience of being diagnosed 
with cancer as a Young Adult, so Josh will ask questions about what life was 
like before and after your diagnosis. Josh will raise some areas for 
discussion, however the main focus and interest is what you think has been 
significant since being diagnosed and as such will generally be led by you.    
  
To ensure that all information is captured during the discussion, a digital 
recorder will be used to record the process. Once the interview has been 
transcribed the recordings will be destroyed. Transcripts will be anonymised 
meaning any information identifying you will be removed.  
  
When Josh begins looking at the data he may wish to spend some time with 
you to go over the main themes from your discussion or to make sure he has 
understood what you meant.  This is so he can make sure he has captured 
your individual experience accurately.   
  
What are the possible advantages and disadvantages of taking part?  
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 Sometimes it is hard to tell people exactly what life is like, especially when 
we are going through something that is difficult. By taking part, you will have 
the opportunity to talk about your own experiences of being diagnosed with 
cancer, from your perspective. Your participation will also hopefully go 
towards helping inform professionals and other young people what life can 
be like as a TYA with cancer.    
  
However, talking about your experience and thinking about what life has 
been like can be difficult. As such, you can stop the interview at any point 
and can take as many breaks as you need. You will also be provided with 
information where you can access further support if required and can talk to 
Josh about being referred to a healthcare professional who can provide 
support.   
  
What will happen with my information?  
 Any personal information provided throughout your participation will remain 
confidential.  Data from the interview between you and Josh will be recorded, 
stored and then destroyed.   
  
You will be assigned an alternative name and this will be used when using 
quotations or providing information from what you talked about. Your data 
will be stored securely on an encrypted storage device, password protected 
computer or in a locked cabinet. The audio recording from the interview will 
be destroyed once Josh has written it up.   
  
All remaining anonymised data will be destroyed in accordance with the 
university’s policy which currently is 5 years. When talking to Josh, if you 
mention yourself or anyone else who might be at-risk, either to themselves or 
from others, Josh may have to tell other professionals in order to keep you 
safe. However, this will always be discussed with you where possible  
  
What will happen to the results of the research?  
This project is being completed as part of Josh’s doctoral thesis which is 
required for the completion of the Clinical Psychology Doctorate program at 
the Universities of Coventry and Warwick.  
  
The results of the study may also be made available to a wider audience via 
meetings, workshops, conferences and/or  publication in  relevant academic 
journals but you will not be identified in any way.  
  
Who has reviewed the study?  
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This project has been approved to be undertaken by the University of 
Coventry’s Research Ethics Committee and the South Birmingham NHS 
Research Ethics Committee.    
  
What if I am not happy about this research or there is a problem?  
 If you have any concerns or queries about the research, please contact the 
lead researcher Joshua Spooner, or the research supervisors Dr Carolyn 
Gordon or Jackie Knibbs (contact details listed below).   
  
If you wish to make a complaint please contact the Associate Pro-Vice- 
Chancellor, Olivier Sparagano on olivier.sparagano@coventry.ac.uk   
If I want to participate in the research, what will happen next?  
If you would like to take part please contact Joshua Spooner (details below) 
who will get back to you to explain what happens next.    
 
Contact details  
 If you have any questions following reading this information sheet, please do 
not hesitate to get in touch to discuss any concerns or questions.   
 Joshua Spooner, Lead Researcher and Trainee Clinical Psychologist. E-
mail: spoone10@uni.coventry.ac.uk  Tel. 024 7765 7806.  
 Dr Carolyn Gordon, or Jackie Knibbs Research Supervisor, Clinical 
Psychology  
Doctorate, Health and Life Sciences, James Starley Building, Coventry 
University, Priory Street, Coventry, CV1 5FB E- mail: / Tel. 024 7765 
7806.  
  
Patient Advice and Liaison Service (PALS) at Queen Elizabeth Hospital 
Birmingham.  
E-mail: PALS@uhb.nhs.uk  
Tel: 0121 371 3280   
 Patient Advice and Liaison Service (PALS) at Birmingham Children’s 
Hospital   
E-mail: bwc.pals@nhs.net  
Tel: 0121 333 8403/ 0121 
333 8505  
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Appendix L 
Participant information sheet 16 and under 
 
  
Participant Information Sheet for 
Participants Under 16  
  
Young peoples’ lived experiences of cancer:   
An Interpretative Phenomenological Analysis  
  
You are being invited to take part in an interview exploring your experiences 
of being diagnosed with cancer. This will form part of a research project 
being completed as part of the researcher’s doctoral thesis which is required 
for the completion of the Clinical Psychology Doctorate program at the 
Universities of Coventry and Warwick. The lead researcher is Joshua 
Spooner, a Trainee Clinical Psychologist  
Before you decide whether you would be interested in taking part, please 
read the following information about the project and what would be involved.  
  
What is the purpose of this research?  
 Research looking at young peoples’ lived experiences of cancer is limited. 
Other projects have largely focused on the physical and social needs of 
young people. This research however wants to focus on what life has been 
like for you during this difficult time.  
 
Why have I been invited to take part in the research?  
 You have been invited to take part in this research because:  
- You are aged between 13-24 years’ old  
- You are 6 -18 months post initial diagnosis    
- You are currently undergoing treatment/are in partial remission   
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Do I have to take part?  
 No. Participation within this study is voluntary; meaning it is entirely up to 
you whether you take part or not.  If you decide not to take part, this will have 
no impact on your treatment.   
If you do wish to take part, you will be asked to sign an assent form and your 
parent/guardian will be asked to provide informed consent on your behalf. In 
order to participate both you and your parent/guardian must agree for you to 
take part.   
You can decide to withdraw your data up to two weeks following the 
interview without giving any reason and again without any consequence. 
This is due to the likelihood of data being analysed after this time. To 
withdraw you just need to contact Josh using the contact details at the end of 
this sheet.   
What will happen to me if I take part?  
 Taking part will involve the completion of a short questionnaire asking a little 
bit about you (your age, type of cancer etc.) and you will have the opportunity 
to discuss the research with Josh before deciding if you would like to sign the 
assent form and take part.   
  
If you do want to go ahead, Josh will write to your GP informing them of your 
participation. He will then contact you to set up a time where you can talk 
about your experiences of being diagnosed with cancer. The amount of time 
this will take will vary, depending on how much you wish to share however it 
should last no longer than 60-70 minutes.    
  
The discussion can be held anywhere that is most convenient for you and 
your parent/guardian, so this could be at home or in a meeting room at your 
local treatment center (Birmingham Children’s Hospital or the Queen 
Elizabeth Hospital) or at Coventry University.  
  
The conversation will largely focus on your experience of being diagnosed 
with cancer as a Teenager, so Josh will ask questions about what life was 
like before and after your diagnosis. Josh will raise some areas for 
discussion, however the main focus and interest is what you think has been 
significant since being diagnosed and as such will generally be led by you.    
  
In order to ensure that all information is captured during the discussion, a 
digital recorder will be used to record the process. Once the interview has 
been transcribed (written up) the recordings will be destroyed. Transcripts 
will be anonymised meaning any information identifying you to you will be 
removed.  
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When Josh begins looking at the data he may wish to spend some time with 
you to go over the main themes from your discussion or to make sure he has 
understood what you meant.  This is so he can make sure he has captured 
your individual experience accurately.   
  
What are the possible advantages and disadvantages of taking part?  
Sometimes it is hard to tell people exactly what life is like, especially when 
we are going through something that is difficult. By taking part, you will have 
the opportunity to talk about your own experiences of being diagnosed with 
cancer, from your perspective. Your participation will also hopefully go 
towards helping inform professionals and other young people what life can 
be like as a teenager with cancer.    
  
However, talking about your experience and thinking about what life has 
been like can be difficult. As such, you can stop the interview at any point 
and can take as many breaks as you need. You will also be provided with 
information where you can access further support if required and can talk to 
Josh about being referred to a healthcare professional who can provide 
support.   
  
What will happen with my information?  
Any personal information provided throughout your participation will remain 
confidential.  Data from the interview between you and Josh will be recorded, 
stored and then destroyed.   
 
You will be assigned an alternative name and this will be used when using 
quotations or providing information from what you talked about. Your data 
will be stored securely on an encrypted storage device, password protected 
computer or in a locked cabinet. The audio recording from the interview will 
be destroyed once Josh has written it up.   
 
All remaining anonymised data will be destroyed in accordance with the 
university’s policy which currently is 5 years. When talking to Josh, if you 
mention yourself or anyone else who might be at-risk, either to themselves or 
from others, Josh may have to tell other professionals in order to keep you 
safe. However, this will always be discussed with you where possible  
  
What will happen to the results of the research?  
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This project is being completed as part of Josh’s doctoral thesis which is 
required for the completion of the Clinical Psychology Doctorate program at 
the Universities of Coventry and Warwick.  
  
The results of the study may also be made available to a wider audience via 
meetings, workshops, conferences and/or publication in relevant academic 
journals but you will not be identified in any way.  
  
Who has reviewed the study?  
 This project has been approved to be undertaken by the University of 
Coventry’s Research Ethics Committee and the South Birmingham NHS 
Research Ethics Committee.   
  
What if I am not happy about this research or there is a problem?  
 If you have any concerns or queries about the research, please contact the 
lead researcher Joshua Spooner, or the research supervisors Dr Carolyn 
Gordon or Jackie Knibbs (contact details listed below).   
  
If you wish to make a complaint please contact the Associate Pro-Vice- 
Chancellor, Olivier Sparagano on olivier.sparagano@coventry.ac.uk   
If I want to participate in the research, what will happen next?  
If you would like to take part please contact Joshua Spooner (details below) 
who will get back to you to explain what happens next.    
 
Contact details  
  
If you have any questions following reading this information sheet, please do 
not hesitate to get in touch to discuss any concerns or questions.   
  
Joshua Spooner, Lead Researcher and Trainee Clinical 
Psychologist. E-mail: spoone10@uni.coventry.ac.uk  Tel. 024 
7765 7806.  
  
Dr Carolyn Gordon, or Jackie Knibbs Research Supervisor, Clinical 
Psychology  
Doctorate, Health and Life Sciences, James Starley Building, Coventry 
University, Priory Street, Coventry, CV1 5FB E- mail: / Tel. 024 7765 
7806.  
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Patient Advice and Liaison Service (PALS) at Queen Elizabeth Hospital 
Birmingham.  
E-mail: PALS@uhb.nhs.uk  
Tel: 0121 371 3280   
Patient Advice and Liaison Service (PALS) at Birmingham Children’s 
Hospital   
E-mail: bwc.pals@nhs.net  
Tel: 0121 333 8403/ 0121 
333 8505   
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Appendix M 
Parent/Legal guardian information sheet 
 
  
Participant Information Sheet   
Parents/Legal Guardian  
  
Young peoples’ lived experiences of cancer:   
An Interpretative Phenomenological Analysis  
  
Your child is being invited to take part in an interview exploring their 
experiences of being diagnosed with cancer. This will form part of a 
research project being completed as part of the researcher’s doctoral 
thesis which is required for the completion of the Clinical Psychology 
Doctorate program at the Universities of Coventry and Warwick. The 
lead researcher is Joshua Spooner, a Trainee Clinical Psychologist.   
  
Before you decide whether you feel this is something your child would 
be interested in, please read the following information about the project 
and what would be involved.  
  
What is the purpose of this research?  
 Previous research looking at young peoples’ lived experiences of cancer is 
limited. Other projects have largely focused on the physical and social needs 
of young people. Whilst important, this project aims to conduct interviews 
that focus on what life is like for young people during this difficult time.  
Why has my child been invited to take part in the research?  
 Your child has been invited to take part in this research because:  
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- They are aged between 13-24 years’ old  
- They are 6 -18 months post initial diagnosis    
- They are currently undergoing treatment   
  
Does my child/relative have to take part?  
 No. Participation within this study is voluntary; meaning it is entirely up to 
you and your child whether they take part.  If you both decide not to take 
part, this will have no impact on their treatment or services, now or in the 
future.   
If you both feel this is something you would like to be involved in, you 
will be asked to sign an informed consent form on behalf of your child 
and they will be required to sign a assent form. In order for them to 
participate both you and your child must agree to take part.   
You and your child can decide to withdraw two weeks following your 
interview without giving any reason and again without any 
consequence. This is due to the likelihood of data being analysed after 
this time. To withdraw you just need to contact Josh using the contact 
details at the end of this sheet.   
  
What will happen to my child if they take part?  
 Taking part will involve the completion of a short questionnaire asking a little 
bit about your child (your age, type of cancer etc.) and you will have the 
opportunity to discuss the research with Josh before deciding if you want 
your child to take part.  
If you do wish to proceed, Josh will write to your child’s GP informing them of 
their participation. He will then set up a time where your child can talk about 
their experiences of being diagnosed with cancer. The amount of time this 
will take will vary, depending on how much they wish to share however it 
should last no longer than 60-70 minutes.   
The discussion can be held anywhere that is most convenient for you and 
your child so this could be at home or in a meeting room at your local 
treatment center (Birmingham Children’s Hospital or the Queen Elizabeth 
Hospital) or at Coventry University.  
 The conversation will largely focus on their experience of being diagnosed 
with cancer as a Teenager or Young Adult (TYA) so Josh will ask questions 
about what life was like before and after their diagnosis. Josh will raise some 
areas for discussion, however the focus and interest is what the young 
person thinks has been significant since being diagnosed and as such will 
generally be led by them.   
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In order to ensure that all information is captured during the discussion, 
a digital recorder will be used to record the process. Once the interview 
has been transcribed the recordings will be destroyed. Transcripts will 
be anonymised meaning any information relating to your child will be 
removed.  
When Josh begins looking at the data he may wish to spend some 
more time with your child to go over the main themes from the 
discussion or to make sure he has understood what they meant.  This is 
so he can make sure he has captured their individual experience 
accurately.   
  
What are the possible advantages and disadvantages of taking 
part?  
Sometimes it is hard to tell people exactly what life is like, especially when 
we are going through something that is difficult. By taking part, your child will 
have the opportunity to talk about their own experiences of being diagnosed 
with cancer, from their perspective. Their participation will also hopefully go 
towards informing professionals of what life can be like as a TYA with 
cancer, as well as provide real accounts to other TYA in a similar position.   
 However, at times talking about our experiences and thinking about what life 
has been like can be difficult. As such, the young person can stop the 
interview at any point and can take as many breaks as they need.  An 
information sheet will also be provided, listing a variety of services where you 
and your child can access further support if required. You can also talk to 
Josh about being referred to a healthcare professional that can provide 
further support.   
  
What will happen with my child’s information?  
Any personal information provided throughout your child’s participation will 
remain confidential.  Data from the interview between them and Josh will be 
recorded and stored before being destroyed.   
 Your child will be assigned an alternative name and this will be used when 
using quotations or providing information from what we have talked about. All 
data will be stored securely on an encrypted storage device, password 
protected computer or in a locked cabinet. The audio recording from the 
interview will be destroyed once Josh has written it up. All remaining 
anonymised data will be destroyed in accordance with the university’s policy 
which currently is 5 years.    
When talking to Josh, if your child talks about themselves or anyone else 
who might be at-risk, either to themselves or from others, Josh may have to 
tell other professionals in order to keep you and your child safe. However, 
this will always be discussed with you where possible.  
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What will happen to the results of the research?  
This research forms part a doctoral thesis which is required for the 
completion of the Clinical Psychology Doctorate program at the Universities 
of Coventry and Warwick. The results of the study may also be made 
available to a wider audience via meetings, workshops, conferences and/or 
publication in relevant academic journals but neither you nor your child will 
be identified in any way.   
Who has reviewed the study?  
This project has been approved to be undertaken by the University of 
Coventry’s Research Ethics Committee and the South Birmingham NHS 
Research Ethics Committee.   
What if I am not happy about this research or there is a problem? If you 
have any concerns or queries about the research, please contact the lead 
researcher Joshua Spooner, or the research supervisors Dr Carolyn Gordon 
or Jackie Knibbs (contact details listed below).   
  
If you wish to make a complaint please contact the Associate Pro-Vice- 
Chancellor, Olivier Sparagano on olivier.sparagano@coventry.ac.uk   
If I agree to my child/relative taking part in the research, what will 
happen next?  
  
If you would like to take part, please contact Joshua Spooner (details 
below) who will get back to you to explain what happens next.    
  
Contact details  
  
If you have any questions following reading this information sheet, please do 
not hesitate to get in touch to discuss any concerns or questions.   
  
Joshua Spooner, Lead Researcher and Trainee Clinical 
Psychologist. E-mail: spoone10@uni.coventry.ac.uk Tel. 
024 7765 7806.  
  
Dr Carolyn Gordon, or Jackie Knibbs Research Supervisor, 
Clinical Psychology Doctorate, Health and Life Sciences, James 
Starley Building, Coventry University, Priory Street, Coventry, CV1 
5FB.   
Tel. 024 7765 7806.  
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Patient Advice and Liaison Service (PALS) at Queen Elizabeth Hospital 
Birmingham.  
E-mail: PALS@uhb.nhs.uk  
Tel: 0121 371 3280   
Patient Advice and Liaison Service (PALS) at Birmingham Children’s 
Hospital   
E-mail: bwc.pals@nhs.net  
Tel: 0121 333 8403/ 
0121 333 8505   
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Appendix N  
Participant informed consent form 16 and over 
  
 
Participant Consent Form for 
Participants aged over 16  
  
Title of Project: Young peoples’ lived experiences of cancer: An 
Interpretative Phenomenological Analysis  
  
  
Name of Participant:                 
  
 Name of Investigator: Joshua Spooner   
  
  
  Please Initial:  
I confirm that I have read the information sheet dated …. 
(version............) for the above study  
  
I have had the opportunity to consider the information, ask 
questions and have had these answered satisfactorily.  
  
I understand that my participation is voluntary and that I am 
free to withdraw at any time without giving any reason, 
without my medical care or legal rights being affected   
   
  
I understand that relevant sections of my medical notes 
and data collected during the study, may be looked at by 
the research team or staff within the NHS Trust, where it is 
relevant to my taking part in this research. I give 
permission for these individuals to have access to my 
records.  
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I understand that the information that I provide during this 
study will be processed and analysed as is required and in 
accordance with the Data Protection Act. This includes an 
audio recording of the interview. I understand that this 
information will be anonymised, all indefinable information 
removed and digital recordings will be destroyed after they 
have been transcribed. After completing the project, 
anonymised transcripts will be held at the university and 
then destroyed in line with university policy  
 
  
  
I agree to anonymised quotes from my interview being 
quoted verbatim in reports and publications related to this 
study.     
  
  
I agree for my GP to be notified of my participation within this 
study   
  
I agree to participate in the above study  
  
As stated in the information sheet, it may be that once the lead researcher 
has been through the interview they wish to interview you again to clarify 
things noticed in the original interview. This is simply to ensure that they 
have a deeper understanding of your experience. If a second interview is 
required and you wish to take part, please initial the following box:  
  
  
I DO wish to take part in a second interview if required    
  
  
  
I wish to see a copy of the results and I would like it emailed/posted to:  
………………………………………………………………………………………… 
………………………………………………………………………………………… 
Signature of Participant …………………………………………………  
  
Name ………………………………………………………  
 
Date  
 
Signature of researcher ………………………………………………… 
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Appendix O 
Parent/Guardian Informed Consent form 16 and under 
 
Informed Consent Form for  
Parents/Legal Guardian   
  
Title of Project: Young peoples’ lived experiences of cancer: An 
Interpretative  
Phenomenological Analysis  
    
  
Name of Parent(s) or Guardian(s):     Name of child/relative:         
    
  
  
Name of Investigator: Joshua Spooner   
  
  
  Please 
Initial:  
I confirm that I have read the information sheet dated …. 
(version............) for the above study  
  
I have had the opportunity to consider the information, ask 
questions and have had these answered satisfactorily.  
  
I understand that my child’s participation is voluntary and 
that they are free to withdraw at any time without giving any 
reason and without their medical care or legal rights being 
affected  
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I understand that relevant sections of my child’s medical 
notes and data collected during the study may be looked at 
by the research team or staff within the NHS Trust, where it 
is relevant to their taking part in this research. I give 
permission for these individuals to have access to my child’s 
ecords.  
  
I understand that the information that my child provides 
during this study will be processed and analysed as is 
required and in accordance with the Data Protection Act. 
This includes an audio recording of the interview. I 
understand that this information will be anonymised, all 
indefinable information removed and digital recordings will 
be destroyed after they have been transcribed. After 
completing the project, anonymised transcripts will be held 
at the university and then destroyed in line with university 
policy  
  
  
I agree to anonymised quotes from my child’s interview 
being quoted verbatim in reports and publications related to 
this study.  
    
  
  
I agree for my child’s GP to be notified of my participation 
within this study  
  
I give informed consent for my child to participate in the above 
study  
  
 
 
As stated in the information sheet, it may be that once the lead researcher 
has been through the interview they wish to interview your child again to 
clarify things noticed in the original interview. This is simply to ensure that 
they have a deeper understanding of their experience.  
  
If a second interview is required and you wish for your child to take 
part, please initial the following box:  
  
  
I DO content to my child/relative taking part in a second 
interview if  
required    
  
  
  
I wish to see a copy of the results and I would like it emailed/posted to:  
………………………………………………………………………………………… 
………………………………………………………………………………………… 
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Signature of Parent(s)/Guardian(s)      
  
 Name ………………………………………………………  
  
 Signature …………………………………………………  
  
 Name ………………………………………………………  
  
 Signature …………………………………………………  
  
        
Name of researcher ………………………  
Signature of researcher…………………  
  
Date:     /      /     /  
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Appendix P  
Participant assent form 16 and under 
  
Assent Form  
(Participants Under16)  
  
Title of Project: Young peoples’ lived experiences of cancer: An  
Interpretative Phenomenological Analysis  
  
Name of Participant:        Name of Investigator: Joshua Spooner   
 
    
  Please Initial:  
I confirm that I have read the information sheet dated …. 
(version............) for the above study  
  
I have had the opportunity to consider the information, ask 
questions and have had these answered satisfactorily.  
  
I understand that my participation is voluntary and that I am 
free to withdraw at any time without giving any reason, 
without my medical care or legal rights being affected   
   
  
I understand that relevant sections of my medical notes 
and data collected during the study, may be looked at by 
the research team or staff within the NHS Trust, where it is 
relevant to my taking part in this research. I give 
permission for these individuals to have access to my 
records.  
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I understand that the information that I provide during this 
study will be processed and analysed as is required and in 
accordance with the Data Protection Act. This includes an 
audio recording of the interview. I understand that this 
information will be anonymised, all indefinable information 
removed and digital recordings will be destroyed after they 
have been transcribed. After completing the project, 
anonymised transcripts will be held at the university and 
then destroyed in line with university policy  
  
I agree to anonymised quotes from my interview being 
quoted verbatim in reports and publications related to this 
study.   
  
I agree for my GP to be notified of my participation within this 
study  
  
I agree to participate in the above study.       
     
As stated in the information sheet, it may be that once the lead researcher 
has been through the interview they wish to interview you again to clarify 
things noticed in the original interview. This is simply to ensure that they 
have a deeper understanding of your experience.  
  
If a second interview is required and you wish to take part, please initial 
the following box:  
  
I DO wish to take part in a second interview if required    
  
  
 
I wish to see a copy of the results and I would like it emailed/posted to:  
………………………………………………………………………………………… 
………………………………………………………………………………………… 
………………………………………………………………………………………… 
Signature of Participant …………………………………………………  
  
Name ………………………………………………………  
  
Date:    
 
Signature of researcher ………………………………………………… 
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Appendix Q 
Participant debrief document 
  
Debrief Sheet  
Young peoples’ lived experiences of cancer:   
An Interpretative Phenomenological Analysis  
  
Thank you for taking the time to participate in this research. The purpose of 
this project was to gain a detailed insight into what it is like to be diagnosed 
with cancer as a teenager or young adult. Your contributions may now go on 
to help other young people who find themselves in a similar position.   
  
I hope you found taking part interesting and enjoyable. However, if this 
experience has brought up any difficult thoughts or feelings, and you feel you 
would like to access some support, now, or in the future, we would 
recommend you speak to your parent/legal guardian or clinical care team. 
Additionally, please see the below list of organisations that can offer advice 
and support if required.   
  
 CLIC Sargent - Cancer charity for children and young 
people  Tel - 03003300803   
Website  http://www.clicsargent.org.uk/content/cancer-
information-youngpeople  
Community Forum  
https://community.clicsargent.org.uk/?_ga=1.68041362.203432
5135.1486377 645  
  
 Cancer Research UK   
Tel -  0808 800 40 40 (9am-5pm Monday to Friday)   
  
 Macmillan Support Line   
Tel - 0808 808 00 00 (9am-8pm Monday to Friday)  
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 The Samaritans   
Tel - 116 123  
  
 ChildLine   
Tel - 0800 1111  
  
 Your clinical care team  
  
 Your GP  
   
Many thanks for your participation 
 
  
Questions   
  
If you have any questions or concerns about the research, please contact:  
  
Joshua Spooner: Lead Researcher and Trainee Clinical Psychologist.                      
E-mail: spoone10@uni.coventry.ac.uk. Tel. 024 7765 7806.  
  
Dr Carolyn Gordon, or Jackie Knibbs: Research Supervisors E- mail:  
carolyn.gordon@coventry.ac.uk/ j.knibbs@coventry.ac.uk Tel. 024 7765 
7806.  
  
If you wish to make a complaint please contact the Associate Pro 
-Vice-Chancellor,  
Olivier Sparagano on olivier.sparagano@coventry.ac.uk   
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Appendix R 
Interpretative Phenomenological Analysis procedure 
 
Table 2.4 IPA analysis procedure (Smith, Flowers & Larkin, 2009) 
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Appendix S 
Examples extracts from coded transcripts 
 
Example from participant 2: 
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Example from participant 4: 
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Appendix T 
Photos of data analysis  
 
Photo one:   
 
 
Photo two:  
 
 
